+ Translate

Biology, Geography & Health: Chapter 6848

Chapter 6848 provides bibliographic information on scholary research in the basic and applied life, earth and health sciences.

Hecht S.S.; Amin S.; Rivenson A.; Hoffmann D., 1979: Tumor initiating activity of 5 11 di methyl chrysene and the structural requirements favoring carcinogenicity of methylated poly nuclear aromatic hydro carbons

Digiovanni J.; Decina P.C.; Diamond L., 1983: Tumor initiating activity of 9 fluoro 7 12 dimethyl benz a anthracene and 10 fluoro 7 12 dimethyl benz a anthracene and the effect of 2 3 7 8 tetra chloro di benzo p dioxin on tumor initiation by mono fluoro derivatives of 7 12 dimethyl benz a anthracene in sencar mice

Levin W.; Wood A.W.; Chang R.L.; Kumar S.; Yagi H.; Jerina D.M.; Lehr R.E.; Conney A.H., 1983: Tumor initiating activity of benz c acridine and 12 of its derivatives on mouse skin

Hecht, S. S.; Rivenson, A.; Hoffmann, D., 1980: Tumor initiating activity of di hydro diols formed metabolically from 5 methyl chrysene

Lavoie E.J.; Amin S.; Hecht S.S.; Furuya K.; Hoffmann D., 1982: Tumor initiating activity of di hydro diols of benzo b fluoranthene benzo j fluoranthene and benzo k fluoranthene

Hecht, S. S.; Hirota, N.; Loy, M.; Hoffmann, D., 1978: Tumor initiating activity of fluorinated 5 methyl chrysenes

Rice J.E.; Hosted T.J.Jr; Defloria M.C.; Lavoie E.J.; Fischer D.L.; Wiley J.C.Jr, 1986: Tumor initiating activity of major in vivo metabolites of indeno 1 2 3 cd pyrene on mouse skin

Mehrotra N.K.; Kumar S.; Shukla Y., 1987: Tumor initiating activity of mancozeb a carbamate fungicide in mouse skin

Lavoie E.J.; Shigematsu A.; Adams E.A.; Rigotty J.; Hoffmann D., 1984: Tumor initiating activity of quinoline and methylated quinolines on the skin of sencar mice

Digiovanni J.; Diamond L.; Prichett W.P.; Fisher E.P.; Harvey R.G., 1985: Tumor initiating activity of the 9 10 dihydrodiol and 9 10 dihydrodiol 7 8 epoxide of 3 methylcholanthrene in sencar mice

Zavanella T.; Presta M.; Braga G.; Dimito E.; Mazzocchi C.; Ziliani S.; Ragnotti G., 1984: Tumor initiating activity of the beta blocker zami 1305 in the liver of the female wistar rat

Wislocki P.G.; Fiorentini K.M.; Fu P.P.; Chou M.W.; Yang S.K.; Lu A.Y.H., 1981: Tumor initiating activity of the di hydro diols of 8 methyl benz a anthracene and 8 hydroxymethyl benz a anthracene

Gerhart J.M.; Hatoum N.S.; Halder C.A.; Warne T.M.; Schmitt S.L., 1988: Tumor initiation and promotion effects of petroleum streams in mouse skin

Goerttler K.; Loehrke H.; Hesse B.; Pyerin W.G., 1982: Tumor initiation by 7 12 di methyl benz a anthracene in dermal melanocytes of hamster inhibition through 7 8 benzo flavone

Lippincott, J. A.; Lippincott, B. B., 1978: Tumor initiation complementation on bean leaves by mixtures of tumorigenic and nontumorigenic agrobacterium rhizogenes

Pyerin W.G.; Hecker E., 1980: Tumor initiation in mouse skin by 7 12 di methyl benz a anthracene irrelevance of systemic activation

Zur Hausen H.; Bornkamm G.W.; Schmidt R.; Hecker E., 1979: Tumor initiators and promoters in the induction of epstein barr virus

Al Mondhiry H.; Mcgarvey V., 1987: Tumor interaction with vascular endothelium

Paling M.R.; Black W.C.; Levine P.A.; Cantrell R.W., 1987: Tumor invasion of the anterior skull base a comparison of mr and ct studies

Mignatti P.; Robbins E.; Rifkin D.B., 1986: Tumor invasion through the human amniotic membrane requirement for a proteinase cascade

Hsu H C.; Wu T T.; Wu M Z.; Sheu J C.; Lee C S.; Chen D S., 1988: Tumor invasiveness and prognosis in resected hepatocellular carcinoma clinical and pathogenetic implications

De Smet A.A.; Levine E.; Neff J.R., 1985: Tumor involvement of peripheral joints other than the knee arthrographic evaluation

Fry, F. J.; Johnson, L. K., 1978: Tumor irradiation with intense ultrasound

Christiansen H.; Lampert F., 1988: Tumor karyotype discriminates between good and bad prognostic outcome in neuroblastoma

Franke F.; Rudolph B.; Christiansen H.; Horbott J.; Lampert F., 1986: Tumor karyotype may be important in the prognosis of human neuroblastoma

Weissler J.C.; Lipscomb M.F.; Lem V.M.; Toews G.B., 1986: Tumor killing by human alveolar macrophages and blood monocytes decreased cytotoxicity of human alveolar macrophages

Spaar F.W.; Goebel H.H.; Volles E.; Wickboldt J., 1981: Tumor like amyloid formation amyloidoma in the brain

Amargier A.; Vago C.; Duthoit J.L.; Meynadier G., 1979: Tumor like formation of parvoviral origin in sibine fusca lepidoptera limacodidae

Felicini G.P.; Perrone C., 1979: Tumor like formations on cultured schottera nicaeensis

Wada Y.; Ikeda J.; Suzuki T., 1987: Tumor like lesions in a human skeleton from the himrin basin of iraq

Nezelof C.; Normand C., 1986: Tumor like massive thymic hyperplasia in childhood a possible defect of t cell maturation histological and cytoenzymatic studies of three cases

Kuehne W., 1983: Tumor like necrotizing granulomatosis of breast

Rebmann K.; Friedel B., 1986: Tumor like osteomyelitis

De Antueno R.J.; Niedfeld G.; De Tomas M.E.; Mercuri O.F.; Quintans C., 1987: Tumor lipids and liver lipid metabolism in the model human lung carcinoma nude mice

Dyatlovitskaya E.V.; Bergel'son L.D., 1982: Tumor lipids and their effect on cell membrane structure and function

Wood, R.; Healy, K., 1970: Tumor lipids biosynthesis of plasmalogens

Schuemichen C.; Weiss H., 1986: Tumor localization and biodistribution of technetium 99m muramylpolypeptide in the rat

Kessel D.; Thompson P.; Saatio K.; Nantwi K.D., 1987: Tumor localization and photosensitization by sulfonated derivatives of tetraphenylporphine

Mach J P.; Chatal J F.; Lumbroso J D.; Buchegger F.; Forni M.; Ritschard J.; Douillard C.J Y.; Carrel S.; Et Al, 1983: Tumor localization in patients by radio labeled mono clonal antibodies against colon carcinoma

Hedin A.; Wahren B.; Hammarstrom S., 1982: Tumor localization of carcino embryonic antigen containing human tumors in nude mice by mono clonal anti carcino embryonic antigen antibodies

Midoux P.; Maillet T.; Therain F.; Monsigny M.; Roche A.C., 1984: Tumor localization of lewis lung carcinoma with radiolabeled monoclonal antibodies

El Far M.; Abou El Zahab M.; Ghoneim M.; Ibrahim E., 1988: Tumor localization of newly developed hematoporphyrin dhp using a bladder tumor model a novel hematoporphyrin derivative

Mach J P.; Carrel S.; Forni M.; Ritschard J.; Donath A.; Alberto P., 1980: Tumor localization of radio labeled goat antibodies against carcino embryonic antigen in patients with carcinoma a critical evaluation

Bubenik J.; Kieler J.; Perlmann P.; Paulie S.; Koho H.; Christensen B.; Dienstbier Z.; Koprivova H.; Pospisil J.; Et Al, 1985: Tumor localization of radiolabeled monoclonal antibody in mice bearing human urinary bladder t 24 carcinoma xenografts

Conti P.S.; Sordillo P.P.; Sordillo E.M.; Schmall B., 1986: Tumor localization of the metabolically trapped radiolabeled substrates 2 deoxy d glucose and aminocyclopentanecarboxylic acid in human melanoma heterotransplants

Paul R.; Johansson R.; Kellokumpu Lehtinen P L.; Soderstrom K O.; Kangas L., 1985: Tumor localization with fluorine 18 2 fluoro 2 deoxy d glucose comparative autoradiography glucose 6 phosphatase histochemistry and histology of renally implanted sarcoma of the rat

Carrano, C. J.; Tsutsui, M.; Mcconnell, S., 1978: Tumor localizing agents the transport of meso tetra p sulfophenyl porphine by vero and hep 2 cells in vitro

Evensen J.F.; Sommer S.; Moan J.; Christensen T., 1984: Tumor localizing and photo sensitizing properties of the main components of hemato porphyrin derivative

Burns R.A.; Klaunig J.E.; Shulok J.R.; Davis W.J.; Goldblatt P.J., 1986: Tumor localizing and photosensitizing properties of hematoporphyrin derivative in hamster buccal pouch carcinoma

Kessel D.; Chou T H., 1983: Tumor localizing components of the porphyrin preparation hemato porphyrin derivative

Schmitt E.L.; Threatt B., 1982: Tumor location and detectability in mammographic screening

Ballou B.; Reiland J.M.; Levine G.; Taylor R.J.; Shen W C.; Ryser H.J P.; Solter D.; Hakala T.R., 1986: Tumor location and drug targeting using a monoclonal antibody anti ssea 1 and antigen binding fragments

Ballou, B.; Reiland, J.; Levine, G.; Knowles, B.; Hakala, T. R., 1985: Tumor location using fab' 2 mu from a monoclonal immunoglobulin m antibody pharmacokinetics

Hubner, K. F.; Andrews, G. A.; Washburn, L.; Wieland, B. W.; Gibbs, W. D.; Hayes, R. L.; Butler, T. A.; Winebrenner, J. D., 1977: Tumor location with carbon 11 labeled 1 amino cyclo pentanecarboxylic acid preliminary clinical trials with single photon detection

Quayle J.B., 1982: Tumor lysis as a factor affecting blood levels of carcino embryonic antigen

Kath, R.; Mueller, M. K.; Hoefeler, H.; Hoeffken, K.; Schmidt, C. G., 1987: Tumor lysis syndrome in an adolescent with burkitt's lymphoma

Cervantes F.; Ribera J.M.; Granena A.; Montserrat E.; Rozman C., 1982: Tumor lysis syndrome with hypo calcemia in accelerated chronic granulocytic leukemia

Friedman F., 1979: Tumor lytic activity of autochthonous blood fractions upon spontaneous murine mammary carcinomas

Whitehead R.; Skinner J.M., 1983: Tumor marker acquisition in the polyp to cancer sequence in the colon

Haglund C., 1986: Tumor marker antigen ca125 in pancreatic cancer a comparison with ca19 9 and cea

Ragaa A.W.; Hamza S.; Nabil H.; El Ansary M.; El Ahmady O.; Rehim M.I.A., 1988: Tumor marker determination in tissues and serum in bladder cancer patients both bilharzial and non bilharzial

Lee A.K.; Rosen P.P.; Delellis R.A.; Saigo P.E.; Gangi M.D.; Groshen S.; Bagin R.; Wolfe H.J., 1985: Tumor marker expression in breast carcinomas and relationship to prognosis an immunohistochemical study

Germa Lluch J.R.; Begent R.H.J.; Bagshawe K.D., 1980: Tumor marker levels and prognosis in malignant teratoma of the testis

Nakajima H.; Hirata T.; Norisugi T.; Furuno K.; Ikehata N.; Utsunomiya A.; Kobayashi K.; Negishi Y.; Akiya K., 1984: Tumor marker of tissue polypeptide antigen in gynecologic malignancies

Shorthouse A.J.; Carter S.M.; Ellison M.L., 1982: Tumor marker production in human bronchial carcinoma xeno grafts

Gion M.; Dittadi R.; Munegato G.; Mione R.; Gurnati G.; Zotti E.F.; Bruscagnin G., 1988: Tumor marker radioimmunoassays in gastric juice

Moncrieff D.; Ormerod M.G.; Coleman D.V., 1984: Tumor marker studies of cervical smears potential for automation

Briese V.; Willroth P O.; Brock J.; Straube W., 1984: Tumor markers alpha 2 macroglobulin secretory immunoglobulin a pregnancy associated alpha 2 glycoprotein in lung cancer patients

Jarvisalo J.; Juntunen J.; Huuskonen M.S.; Kivisto H.; Aitio A., 1984: Tumor markers and neurological signs in asbestosis patients

Von Kleist S., 1986: Tumor markers as target substances in the radioimmunological detection of malignancies

Roethlin, M.; Metzger, U.; Joller, H.; Largiader, F., 1988: Tumor markers ca 19.9 ca 50 and cea in differential diagnosis of pancreatic cancer

Harmenberg U.; Wahren B.; Wiechel K L., 1988: Tumor markers carbohydrate antigens ca 19 9 and ca 50 and carcinoembryonic antigen in pancreatic cancer and benign diseases of the pancreatobiliary tract

Putzki H.; Ledwoch J.; Student A.; Jablonski M.; Heymann H., 1988: Tumor markers carcinoembryonic antigen tissue polypeptide antigen and carbohydrate antigen 19 9 in liver diseases

Kodaira S.; Watanabe M.; Okuda K.; Takada Y.; Hara A.; Teramoto T.; Abe O.; Hirohashi S., 1985: Tumor markers carcinoembryonic antigen x hapaten y hapten ca 19 9 and ncc st 439 antigens in the tissue of colorectal carcinoma

Ishii M., 1985: Tumor markers for colonic cancer

Lokich, J. J., 1978: Tumor markers hormones antigens and enzymes in malignant disease

Kroll J.; Andersen M.M., 1988: Tumor markers identified by line immunoelectrophoresis

Bosl G.J.; Lange P.H.; Nochomovitz L.E.; Goldmann A.; Fraley E.E.; Rosai J.; Johnson K.; Kennedy B.J., 1981: Tumor markers in advanced nonseminomatous testicular cancer

Cove D.H.; Woods K.L.; Smith S.C.H.; Burnett D.; Leonard J.; Grieve R.J.; Howell A., 1979: Tumor markers in breast cancer

Buccheri G.F.; Ferrigno D.; Sartoris A.M.; Violante B.; Vola F.; Curcio A., 1987: Tumor markers in bronchogenic carcinoma superiority of tissue polypeptide antigen to carcinoembryonic antigen and carbohydrate antigenic determinant 19 9

Skinner J.M.; Whitehead R., 1982: Tumor markers in carcinoma and pre malignant states of the stomach in humans

Khalifa A.A.; Ismail H.M.; Gomaa A.; El Mahady O.; Khalid H.; Reda H.M., 1988: Tumor markers in chronic obstructive airway disease coad in relation to bronchial carcinoma

Rasmuson T.; Bjork G.R.; Damber L.; Holm S.E.; Jacobsson L.; Jeppsson A.; Stigbrand T.; Westman G., 1984: Tumor markers in colorectal carcinoma an evaluation of carcinoembryonic antigen tissue polypeptide antigen placental alkaline phosphatase and pseudouridine

Mezger J.; Lamerz R.; Arnholdt H.; Huhn D.; Wilmanns W., 1986: Tumor markers in diagnosis of serous effusions

Kasatkin Yu N.; Ametov A.S.; Mit'kov V.V.; Sevast'yanov S.I.; Zarudin V.V., 1984: Tumor markers in focal and diffuse hepatic diseases

Geyer H.; Kleine W., 1987: Tumor markers in gynecologic diseases

Onnis A.; Maggino T.; Marchetti M., 1985: Tumor markers in gynecological oncology

Blaustein A.; Kaganowicz A.; Wells J., 1982: Tumor markers in inclusion cysts of the ovary

Rasmuson T.; Bjork G.R.; Damber L.; Jacobsson L.; Jeppsson A.; Stigbrand T.; Westman G., 1987: Tumor markers in mammary carcinoma an evaluation of carcinoembryonic antigen placental alkaline phosphatase pseudouridine and ca 50

Margariti P.A.; Panici P.B.; Villani L.; Di Roberto P.; Maiorca A.; Sacco F.; Bompiani A., 1980: Tumor markers in ovarian carcinoma

Pflueger K H.; Gropp C.; Havemann K., 1981: Tumor markers in patients with lung cancer their relevance for early diagnosis staging and monitoring of therapy

Willemse P.H.B.; Sleijfer D.T.; Koops H.S.; De Bruijn H.W.A.; Oosterhuis J.W.; Brouwers T.M.; Ockhuizen T.; Marrink J., 1981: Tumor markers in patients with nonseminomatous germ cell tumors of the testis

Tamura S.; Nishigaki T.; Moriwaki Y.; Fujioka H.; Nakano T.; Fujii J.; Yamamoto T.; Nabeshima K.; Hada T.; Higashino K., 1988: Tumor markers in pleural effusion diagnosis

Bhatavdekar J.M.; Trivedi S.N.; Desai N.D.; Balar D.B.; Patel G.H.; Sheth J.J., 1984: Tumor markers in primary and metastatic liver cancer possible value in early detection and differentiation

Ferro M.A.; Barnes I.; Roberts J.B.M.; Smith P.J.B., 1987: Tumor markers in prostatic carcinoma a comparison of prostate specific antigen with acid phosphatase

Ozhiganov E.L.; Kuznetsova L.F., 1985: Tumor markers in rectal cancer

Uchida T.; Shinohara K.; Kobayashi K.; Honda N.; Ao T.; Omata T.; Odajima K.; Koshiba K., 1986: Tumor markers in renal cell carcinoma

Maehara S.; Kawashita E.; Ishibe T.; Nagaoka S., 1985: Tumor markers in renal cell carcinoma changes in urinary trypsin inhibitor serum alpha 1 antitrypsin alpha 2 macroglobulin inter alpha trypsin inhibitor and plasma fibrinogen levels in patients with renal cell carcinoma

Norgaard Pedersen B.; Schultz H.P.; Arends J.; Brincker H.; Krag Jacobsen G.; Lindelov B.; Rorth M.; Svennekjaer I.L.; Dan Testicular Carcinoma Study Group, 1984: Tumor markers in testicular germ cell tumors 5 year experience from the danish testicular carcinoma study 1976 1980

Van Zanten A.P.; Twijnstra A.; De Visser B.W.O.; Hart A.A.M.; Nooyen W.J., 1988: Tumor markers in the cerebrospinal fluid of patients with central nervous system metastases from extracranial malignancies

Czalberth H.J.; Hornok L., 1987: Tumor markers in the follow up of patients with colorectal tumors experience with cea

Nouwen E.J.; Hendrix P.G.; Dauwe S.; Eerdekens M.W.; De Broe M.E., 1987: Tumor markers in the human ovary and its neoplasms a comparative immunohistochemical study

Desanto N.G.; Veneroso S.; Capodicasa G.; Crisci A.; Giordano C., 1986: Tumor markers in uremia carcinoembryonic antigen neuron specific enolase carbohydrate antigen ca 50 and alpha fetoprotein

Screm, M. C.; De-Biasi, F.; Scalia, A.; Franzon, R.; Englaro, E., 1987: Tumor markers of the gastrointestinal tract preliminary comparison between cea and gastrointestinal cancer antigen ca 19.9

Briese V.; Szabo D.G.; Than G.N.; Willroth P.O.; Straube W., 1986: Tumor markers orosomucoid pregnancy associated alpha 2 glycoprotein schwangerschaftsprotein 1 placental specific tissue protein 10 placental specific tissue protein 12 alpha 1 fetoprotein in lung cancer patients

Manguso L.; Musset M.; Coraggio F.; Grimaldi G.; Zito G.A.; Gattoni A.; Catalano G.; Astarita C.; Papaleo G.; Di Domenico M., 1984: Tumor markers present day utilization in antitumor strategy

Briese V.; Strache R R.; Buettner H.H.; Kunze M.; Brock J.; Roepcke G., 1987: Tumor markers secretory immunoglobulin a circulating immune complexes pregnancy associated alpha 2 glycoprotein in breast cancer disease

Price M.R.; Mclaughlin P.J.; Robins R.A.; Baldwin R.W.; Vasey D.; Symonds E.M., 1980: Tumor markers with unknown functions in gynecological neoplasia

Euhus D.M.; Hudd C.; La Regina M.C.; Johnson F.E., 1986: Tumor measurement in the nude mouse

Grinwich, K. D.; Plescia, O. J., 1977: Tumor mediated immuno suppression prevention by inhibitors of prostaglandin synthesis

Hemstreet, G. P.; Dawson, J. R.; Seigler, H. F., 1978: Tumor membrane lymphocyte stimulation assay in patients with renal cell carcinoma

Schirrmacher, V.; Bosslet, K., 1980: Tumor metastases and cell mediated immunity in a model system in dba 2 mice 10. immuno selection of tumor variants differing in tumor antigen expression and metastatic capacity

Bosslet, K.; Schirrmacher, V.; Shantz, G., 1979: Tumor metastases and cell mediated immunity in a model system in dba 2 mice 6. similar specificity patterns of protective anti tumor immunity in vivo and cytolytic thymus derived cells in vitro

Lohmann-Matthes, M. L.; Schleich, A.; Shantz, G.; Schirrmacher, V., 1980: Tumor metastases and cell mediated immunity in a model system in dba 2 mice 7. interaction of metastasizing and nonmetastasizing tumors with normal tissue in vitro

Schirrmacher, V.; Jacobs, W., 1979: Tumor metastases and cell mediated immunity in a model system in dba 2 mice 8. expression and shedding of fc gamma receptors on metastatic tumor cell variants

Schirrmacher V.; Shantz G.; Clauer K.; Komitowski D.; Zimmermann H P.; Lohmann Matthes M L., 1979: Tumor metastases and cell mediated immunity in a model system in dba 2 mice part 1 tumor invasiveness in vitro and metastasis formation in vivo

Schirrmacher V.; Bosslet K.; Shantz G.; Clauer K.; Huebsch D., 1979: Tumor metastases and cell mediated immunity in a model system in dba 2 mice part 4 antigenic differences between a metastasizing variant and the parental tumor line revealed by cyto toxic thymus derived lymphocytes

Schirrmacher V., 1979: Tumor metastases and cell mediated immunity in a model system in dba 2 mice part 5 transfer of protective immunity with h 2 identical immune thymus derived cells from b 10d 2 mice

Gherman G.; Marza V.; Larzarov P., 1980: Tumor metastases with an undetermined starting point

Adamson I.Y.R.; Young L.; Orr F.W., 1987: Tumor metastasis after hyperoxic injury and repair of the pulmonary endothelium

Nakajima M.; Irimura T.; Nicolson G.L., 1986: Tumor metastasis associated heparanase heparan sulfate endoglycosidase activity in human melanoma cells

Stellato T.A.; Gauderer M.W.L.; Kazura J., 1985: Tumor metastasis from multiple myeloma and burkitts lymphoma in broviac catheter tracts

Suurkula, M.; Boeryd, B., 1975: Tumor metastasis in mice with reduced immune reactivity part 4 restoration of relative resistance to metastasis formation in thymectomized sublethally irradiated mice by spleen cells

Nicolson G.L.; Custead S.E., 1982: Tumor metastasis is not due to adaptation of cells to a new organ environment

Michelson S.; Miller B.E.; Glicksman A.S.; Leith J.T., 1987: Tumor micro ecology and competitive interactions

Gyongyossy Issa M.I.; Khachatourians G.G., 1985: Tumor minicells single large vesicles released from cultured mastocytoma cells

Randerath K.; Agrawal H.P.; Randerath E., 1981: Tumor mitochondrial transfer rna the nucleotide sequence of mitochondrial leucine transfer rna anti codon uracil adenine guanine from morris hepatoma 5123d

Chauncey, D. M.; Halpern, S. E.; Hagan, P. L.; Alazraki, N. P., 1976: Tumor model studies of iodine 131 tetracycline and other compounds

Goudarzi H.A.; Lyttle J.A.; Mundy A.R., 1984: Tumor morphometry as prognostic factor in t 1 and t 2 bladder cancer

Hildebrand H.F.; Kerckaert J P.; Biserte G.; Tetaert D.; Grandier Vazeille X., 1980: Tumor myosins of nickel sulfide induced rhabdo myo sarcomas in rat and rabbit comparative studies with adult and fetal myosins of skeletal muscle

Weiss, L., 1977: Tumor necrosis and cell detachment

Bonfil R.D.; Bustuoabad O.D.; Ruggiero R.A.; Meiss R.P.; Pasqualini C.D., 1988: Tumor necrosis can facilitate the appearance of metastases

Urban J.L.; Shepard H.M.; Rothstein J.L.; Sugarman B.J.; Schreiber H., 1986: Tumor necrosis factor a potent effector molecule for tumor cell killing by activated macrophages

Bagavandoss P.; Kunkel S.L.; Wiggins R.C.; Keyes P.L., 1988: Tumor necrosis factor a tnf a production and localization of macrophages and t lymphocytes in the rabbit corpus luteum

Bermudez L.E.M.; Young L.S., 1988: Tumor necrosis factor alone or in combination with il 2 but not ifn gamma is associated with macrophage killing of mycobacterium avium complex

Seliger B.; Stark G.; Pfizenmaier K., 1988: Tumor necrosis factor alpha affects ltr controlled oncogene expression in transformed mouse fibroblast at the post transcriptional level

Roodman G.D.; Bird A.; Hutzler D.; Montgomery W., 1987: Tumor necrosis factor alpha and hematopoietic progenitors effects of tumor necrosis factor on the growth of erythroid progenitors cfu e and bfu e and the hematopoietic cell lines k562 hl60 and hel cells

Ranges G.E.; Zlotnik A.; Espevik T.; Dinarello C.A.; Cerami A.; Palladino M.A.Jr, 1988: Tumor necrosis factor alpha cachectin is a growth factor for thymocytes synergistic interactions with other cytokines

Tashjian A.H.Jr; Voelkel E.F.; Lazzaro M.; Goad D.; Bosma T.; Levine L., 1987: Tumor necrosis factor alpha cachectin stimulates bone resorption in mouse calvaria via a prostaglandin mediated mechanism

Ostensen M.E.; Thiele D.L.; Lipsky P.E., 1987: Tumor necrosis factor alpha enhances cytolytic activity of human natural killer cells

Leist T.P.; Frei K.; Kam Hansen S.; Zinkernagel R.M.; Fontana A., 1988: Tumor necrosis factor alpha in cerebrospinal fluid during bacterial but not viral meningitis evaluation in murine model infections and in patients

Hoffman M.; Weinberg J.B., 1987: Tumor necrosis factor alpha induces increased hydrogen peroxide production and fc receptor expression but not increased ia antigen expression by peritoneal macrophages

Solis Herruzo J.A.; Brenner D.A.; Chojkier M., 1988: Tumor necrosis factor alpha inhibits collagen gene transcription and collagen synthesis in cultured human fibroblasts

Centrella M.; Mccarthy T.L.; Canalis E., 1988: Tumor necrosis factor alpha inhibits collagen synthesis and alkaline phosphatase activity independently of its effect on dna synthesis in osteoblast enriched bone cell cultures

Feingold K.R.; Grunfeld C., 1987: Tumor necrosis factor alpha stimulates hepatic lipogenesis in the rat in vivo

Kvale D.; Lovhaug D.; Sollid L.M.; Brandtzaeg P., 1988: Tumor necrosis factor alpha up regulates expression of secretory component the epithelial receptor for polymeric ig

Massa P.T.; Schimpl A.; Wecker E.; Ter Meulen V., 1987: Tumor necrosis factor amplifies measles virus mediated ia induction on astrocytes

Beran, M.; O'brien, S.; Gutterman, J. U.; Mccredie, K. B., 1988: Tumor necrosis factor and human hematopoiesis i. kinetics and diversity of human bone marrow cell response to recombinant tumor necrosis factor alpha in short term suspension cultures in vitro

Beran, M.; O'brien, S.; Andersson, B.; Mccredie, K. B.; Gutterman, J. U., 1988: Tumor necrosis factor and human hematopoiesis ii. inhibition and mode of action on normal and chronic myelogenous leukemia derived granulocyte macrophage progenitor cells

Rubin B.Y.; Anderson S.L.; Lunn R.M.; Richardson N.K.; Hellermann G.R.; Smith L.J.; Old L.J., 1988: Tumor necrosis factor and ifn induce a common set of proteins

Ichinose Y.; Bakouche O.; Tsao J.Y.; Fidler I.J., 1988: Tumor necrosis factor and il 1 associated with plasma membranes of activated human monocytes lyse monokine sensitive but not monokine resistant tumor cells whereas viable activated monocytes lyse both

Stolpen A.H.; Golan D.E.; Pober J.S., 1988: Tumor necrosis factor and immune interferon act in concert to slow the lateral diffusion of proteins and lipids in human endothelial cell membranes

Plata Salaman C.R.; Oomura Y.; Kai Y. , 1988: Tumor necrosis factor and interleukin 1 beta suppression of food intake by direct action in the central nervous system

Le J.; Reis L.F.L.; Vilcek J., 1988: Tumor necrosis factor and interleukin 1 can act as essential growth factors in a murine plasmacytoma line

Lin J X.; Vilcek J., 1987: Tumor necrosis factor and interleukin 1 cause a rapid and transient stimulation of c fos and c myc messenger rna levels in human fibroblasts

Girardin E.; Grau G.E.; Dayer J M.; Roux Lombard P.; J5 Study Group; Lambert P H., 1988: Tumor necrosis factor and interleukin 1 in the serum of children with severe infectious purpura

Meichele A.; Hensel G.; Pfizenmaier K.; Kroenke M., 1988: Tumor necrosis factor and lymphotoxin gene expression in human tumor cell lines

Trinchieri G.; Kobayashi M.; Rosen M.; Loudon R.; Murphy M.; Perussia B., 1986: Tumor necrosis factor and lymphotoxin induce differentiation of human myeloid cell lines in synergy with immune interferon

Paya C.V.; Kenmotsu N.; Schoon R.A.; Leibson P.J., 1988: Tumor necrosis factor and lymphotoxin secretion by human natural killer cells leads to antiviral cytotoxicity

Sakurai A.; Satomi N.; Haranaka K., 1985: Tumor necrosis factor and the lysosomal enzymes of macrophages or macrophage like cell line

Cordingley F.T.; Hoffbrand A.V.; Heslop H.E.; Turner M.; Bianchi A.; Reittie J.E.; Vyakarnam A.; Meager A.; Brenner M.K., 1988: Tumor necrosis factor as an autocrine tumor growth factor for chronic b cell malignancies

Tamatani T.; Urawa H.; Hashimoto T.; Onozaki K., 1987: Tumor necrosis factor as an interleukin 1 dependent differentiation inducing factor d factor for mouse myeloid leukemic cells

Ziegler Heitbrock H.W.L.; Moeller A.; Linke R.P.; Haas J.G.; Rieber E.P.; Riethmueller G., 1986: Tumor necrosis factor as effector molecule in monocyte mediated cytotoxicity

Ferrante, A.; Nandoskar, M.; Bates, E. J.; Goh, D. H. B.; Beard, L. J., 1988: Tumor necrosis factor beta lymphotoxin inhibits locomotion and stimulates the respiratory burst and degranulation of neutrophils

Grau G.E.; Fajardo L.F.; Piguet P F.; Allet B.; Lambert P H.; Vassalli P., 1987: Tumor necrosis factor cachectin as an essential mediator in murine cerebral malaria

Nawroth P.; Handley D.; Matsueda G.; De Waal R.; Gerlach H.; Blohm D.; Stern D., 1988: Tumor necrosis factor cachectin induced intravascular fibrin formation in meth a fibrosarcomas

Clark M.A.; Chen M J.; Crooke S.T.; Bomalaski J.S., 1988: Tumor necrosis factor cachectin induces phospholipase a 2 activity and synthesis of a phospholipase a 2 activating protein in endothelial cells

Nawroth P.P.; Bank I.; Handley D.; Cassimeris J.; Chess L.; Stern D., 1986: Tumor necrosis factor cachectin interacts with endothelial cell receptors to induce release of interleukin 1

Piguet, P. F.; Grau, G. E.; Allet, B.; Vassalli, P., 1987: Tumor necrosis factor cachectin is an effector of skin and gut lesions of the acute phase of graft vs. host disease

Dinarello C.A.; Cannon J.G.; Wolff S.M.; Bernheim H.A.; Beutler B.; Cerami A.; Figari I.S.; Palladino M.A.Jr; O'connor J.V., 1986: Tumor necrosis factor cachectin is an endogenous pyrogen and induces production of interleukin 1

Tarleton, R. L., 1988: Tumor necrosis factor cachectin production during experimental chagas' disease

Camussi G.; Bussolino F.; Salvidio G.; Baglioni C., 1987: Tumor necrosis factor cachectin stimulates peritoneal macrophages polymorphonuclear neutrophils and vascular endothelial cells to synthesize and release platelet activating factor

Kettelhut I.C.; Goldberg A.L., 1988: Tumor necrosis factor can induce fever in rats without activating protein breakdown in muscle or lipolysis in adipose tissue

Stephens K.E.; Ishizaka A.; Larrick J.W.; Raffin T.A., 1988: Tumor necrosis factor causes increased pulmonary permeability and edema comparison to septic acute lung injury

Jensen J.B.; Vande Waa J.A.; Karadsheh A.J., 1987: Tumor necrosis factor does not induce plasmodium falciparum crisis forms

Silberstein D.S.; David J.R., 1986: Tumor necrosis factor enhances eosinophil toxicity to schistosoma mansoni larvae

Pfizenmaier K.; Scheurich P.; Schlueter C.; Kroenke M., 1987: Tumor necrosis factor enhances hla a b c and hla dr gene expression in human tumor cells

Wright J.R.Jr; Epstein H.R.; Hauptfeld V.; Lacy P.E., 1988: Tumor necrosis factor enhances interferon induced ia antigen expression on murine islet parenchymal cells

Varani J.; Bendelow M.J.; Sealey D.E.; Kunkel S.L.; Gannon D.E.; Ryan U.S.; Ward P.A., 1988: Tumor necrosis factor enhances susceptibility of vascular endothelial cells to neutrophil mediated killing

Alexander R.B.; Isaacs J.T.; Coffey D.S., 1987: Tumor necrosis factor enhances the in vitro and in vivo efficacy of chemotherapeutic drugs targeted at dna topoisomerase ii in the treatment of murine bladder cancer

Spriggs D.R.; Imamura K.; Rodriguez C.; Sariban E.; Kufe D.W., 1988: Tumor necrosis factor expression in human epithelial tumor cell lines

Matthews, N., 1979: Tumor necrosis factor from the rabbit 3. relationship to interferons

Matthews, N.; Ryley, H. C.; Neale, M. L., 1980: Tumor necrosis factor from the rabbit 4. purification and chemical characterization

Matthews, N., 1981: Tumor necrosis factor from the rabbit 5. synthesis in vitro by mononuclear phagocytes from various tissues of normal and bcg injected rabbits

Matthews, N.; Watkins, J. F., 1978: Tumor necrosis factor from the rabbit part 1 mode of action specificity and physicochemical properties

Matthews, N., 1978: Tumor necrosis factor from the rabbit part 2 production by monocytes

Shklar G.; Schwartz J., 1988: Tumor necrosis factor in experimental cancer regression with alpha tocopherol beta carotene canthaxanthin and algae extract

Selby P.; Hobbs S.; Viner C.; Jackson E.; Jones A.; Newell D.; Calvert A.H.; Mcelwain T.; Fearon K.; Humphreys J.; Shiga T., 1987: Tumor necrosis factor in man clinical and biological observations

Di Giovine F.S.; Nuki G.; Duff G.W., 1988: Tumor necrosis factor in synovial exudates

Meszaros K.; Lang C.H.; Bagby G.J.; Spitzer J.J., 1987: Tumor necrosis factor increases in vivo glucose utilization of macrophage rich tissues

Palombella V.J.; Yamashiro D.J.; Maxfield F.R.; Decker S.J.; Vilcek J., 1987: Tumor necrosis factor increases the number of epidermal growth factor receptors on human fibroblasts

Lehmmann V.; Benninghoff B.; Droege W., 1988: Tumor necrosis factor induced activation of peritoneal macrophages is regulated by prostaglandin e 2 and cyclic amp

Remick D.G.; Larrick J.; Kunkel S.L., 1986: Tumor necrosis factor induced alterations in circulating leukocyte populations

Schuetze S.; Scheurich P.; Schuelter C.; Uecer U.; Pfizenmaier K.; Kroenke M., 1988: Tumor necrosis factor induced changes of gene expression in u937 cells differentiation dependent plasticity of the responsive state

Tsujimoto M.; Vilcek J., 1987: Tumor necrosis factor induced downregulation of its receptors in hela cells

Oku N.; Araki R.; Araki H.; Shibamoto S.; Ito F.; Nishihara T.; Tsujimoto M., 1987: Tumor necrosis factor induced permeability increase of negatively charged phospholipid vesicles

Urbaschek R.; Mannel D.N.; Urbaschek B., 1987: Tumor necrosis factor induced stimulation of granulopoiesis and radioprotection

Lavi E.; Suzumura A.; Murasko D.M.; Murray E.M.; Silberberg D.H.; Weiss S.R., 1988: Tumor necrosis factor induces expression of mhc class i antigens on mouse astrocytes

Kirstein M.; Baglioni C., 1986: Tumor necrosis factor induces synthesis of two proteins in human fibroblasts

Conkling P.R.; Greenberg C.S.; Weinberg J.B., 1988: Tumor necrosis factor induces tissue factor like activity in human leukemia cell line u937 and peripheral blood monocytes

Arata S.; Nakaya K.; Furuhashi H.; Nakamura Y.; Hirayama T.; Mashimo J I.; Kasai N., 1988: Tumor necrosis factor inducing activities of lipid a preparations from pseudomonas diminuta and pseudomonas vesicularis

Aderka D.; Holtmann H.; Toker L.; Hahn T.; Wallach D., 1986: Tumor necrosis factor induction by sendai virus

Sato N.; Fukuda K.; Nariuchi H.; Sagara N., 1987: Tumor necrosis factor inhibiting angiogenesis in vitro

Gordon T.; Sheppard D., 1988: Tumor necrosis factor inhibits a polymorphonuclear leukocyte dependent airway edema in guinea pigs

Miller S.C.; Ito H.; Blau H.M.; Torti F.M., 1988: Tumor necrosis factor inhibits human myogenesis in vitro

Kroenke M.; Schlueter C.; Pfizenmaier K., 1987: Tumor necrosis factor inhibits myc expression in hl 60 cells at the level of messenger rna transcription

Schweigerer L.; Malerstein B.; Gospodarowicz D., 1987: Tumor necrosis factor inhibits the proliferation of cultured capillary endothelial cells

Elias J.A., 1988: Tumor necrosis factor interacts with interleukin 1 and interferons to inhibit fibroblast proliferation via fibroblast prostaglandin dependent and independent mechanisms

Feinman R.; Henriksen Destefano D.; Tsujimoto M.; Vilcek J., 1987: Tumor necrosis factor is an important mediator of tumor cell killing by human monocytes

Ming W.J.; Bersani L.; Mantovani A., 1987: Tumor necrosis factor is chemotactic for monocytes and polymorphonuclear leukocytes

Nakaya K.; Nakajo S.; Shimizu T.; Hayashi Y.; Nakamura Y., 1987: Tumor necrosis factor is partly responsible for the differentiation of mouse myeloid leukemia cells

Berger M.; Wetzler E.M.; Wallis R.S., 1988: Tumor necrosis factor is the major monocyte product that increases complement receptor expression on mature human neutrophils

Espevik T.; Nissen Meyer J., 1987: Tumor necrosis factor like activity on paraformaldehyde fixed monocyte monolayers

Clark I.A.; Chaudhri G., 1988: Tumor necrosis factor may contribute to the anemia of malaria by causing dyserythropoiesis and erythrophagocytosis

Agarwal S.; Drysdale B E.; Shin H.S., 1988: Tumor necrosis factor mediated cytotoxicity involves adp ribosylation

Hajjar K.A.; Hajjar D.P.; Silverstein R.L.; Nachman R.L., 1987: Tumor necrosis factor mediated release of platelet derived growth factor from cultured endothelial cells

Bauss F.; Droege W.; Maennel D.N., 1987: Tumor necrosis factor mediates endotoxic effects in mice

Selmaj K.W.; Raine C.S., 1988: Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro

Kornbluth R.S.; Edgington T.S., 1986: Tumor necrosis factor production by human monocytes is a regulated event induction of tumor necrosis factor alpha mediated cellular cytotoxicity by endotoxin

Bachwich P.R.; Lynch J.P.IIi; Larrick J.; Spengler M.; Kunkel S.L., 1986: Tumor necrosis factor production by human sarcoid alveolar macrophages

Tsujimoto M.; Yokota S.; Vilcek J.; Weissmann G., 1986: Tumor necrosis factor provokes superoxide anion generation from neutrophils

Johnson S.E.; Baglioni C., 1988: Tumor necrosis factor receptors and cytocidal activity are down regulated by activators of protein kinase c

Munker R.; Dipersio J.; Koeffler H.P., 1987: Tumor necrosis factor receptors and hematopoietic cells

Tsujimoto M.; Vilcek J., 1986: Tumor necrosis factor receptors in hela cells and their regulation by interferon gamma

Yardin A.; Kimchi A., 1986: Tumor necrosis factor reduces c myc expression and cooperates with interferon gamma in hela cells

Janssen O.; Kabelitz D., 1988: Tumor necrosis factor selectively inhibits activation of human b cells by epstein barr virus

Tsujimoto M.; Yip Y.K.; Vilcek J., 1985: Tumor necrosis factor specific binding and internalization in sensitive and resistant cells

Feingold K.R.; Soued M.; Grunfeld C., 1988: Tumor necrosis factor stimulates dna synthesis in the liver of intact rats

Nakagawa H.; Kitagawa H.; Aikawa Y., 1987: Tumor necrosis factor stimulates gelatinase and collagenase production by granulation tissue in culture

Bachwich P.R.; Chensue S.W.; Larrick J.W.; Kunkel S.L., 1986: Tumor necrosis factor stimulates interleukin 1 and prostaglandin e 1 production in resting macrophages

Kirstein M.; Baglioni C., 1988: Tumor necrosis factor stimulates proliferation of human osteosarcoma cells and accumulation of c myc messenger rna

Oster W.; Lindemann A.; Horn S.; Mertelsmann R.; Hermann F., 1987: Tumor necrosis factor tnf alpha but not tnf beta induces secretion of colony stimulating factor for macrophages csf 1 by human monocytes

Frater Schroeder M.; Risau W.; Hallmann R.; Gautschi P.; Boehlen P., 1987: Tumor necrosis factor type alpha a potent inhibitor of endothelial cell growth in vitro is angiogenic in vivo

Sato K.; Fujii Y.; Kasono K.; Kawakami M.; Tsushima T.; Shizume K., 1987: Tumor necrosis factor type alpha cachectin stimulates mouse osteoblast like cells mc3t3 e1 to produce macrophage colony stimulating activity and prostaglandin e 2

Broudy V.C.; Kaushansky K.; Segal G.M.; Harlan J.M.; Adamson J.W., 1986: Tumor necrosis factor type alpha stimulates human endothelial cells to produce granulocyte macrophage colony stimulating factor

Locksley R.M.; Heinzel F.P.; Shepard H.M.; Agosti J.; Eessalu T.E.; Aggarwal B.B.; Harlan J.M., 1987: Tumor necrosis factors alpha and beta differ in their capacities to generate interleukin 1 release from human endothelial cells

Ammann A.J.; Palladino M.A.; Volberding P.; Abrams D.; Martin N.L.; Conant M., 1987: Tumor necrosis factors alpha and beta in acquired immunodeficiency syndrome aids and aids related complex

Thomson B.M.; Mundy G.R.; Chambers T.J., 1987: Tumor necrosis factors alpha and beta induce osteoblastic cells to stimulate osteoclastic bone resorption

Chun M.; Pasenen V.; Haemmerling U.; Hammerling G.F.; Hoffmann M.K., 1979: Tumor necrosis serum induces a serologically distinct population of natural killer cells

Scuderi P.; Rosse C. , 1981: Tumor neutralization by immune in vitro sensitized splenocytes depends on interaction with b cells

Cheever, M. A.; Kempf, R. A.; Fefer, A., 1977: Tumor neutralization immuno therapy and chemo immuno therapy of a friend leukemia with cells secondarily sensitized in vitro

Fries, R.; Grabner, H.; Leijhanec, J.; Wepner, F.; Kraenzl, B.; Krekeler, G.; Kriens, O.; Mehnert, H.; Platz, H.; Et-Al, 1976: Tumor node metastasis classification of carcinomas of the oral cavity efficacy of clinically available data tumor node

Niijima T.; Tsuji I.; Suzuki K.; Yokokawa M.; Matsumoto K.; Tsugawa R.; Miyagawa M.; Kotake T.; Et Al, 1980: Tumor node metastasis classification of urinary bladder tumors

Izuo M.; Kuno K.; Watanabe H., 1982: Tumor node metastasis staging of breast cancer in japan a summary of a prospective survey over a 13 year period 1963 1975

Batata M.A.; Chu F.C.H.; Hilaris B.S.; Witmore W.F.Jr; Grabstald H.; Golbey R., 1980: Tumor node metastasis staging of testis cancer

Demin, V. N.; Shal'neva, T. S.; Sidorenko, L. N., 1976: Tumor node metastasis system classification of infiltrative edematous forms of breast cancer

Fisher B.; Fisher E.R.; Redmond C.; Brown A.; Nsabp, 1986: Tumor nuclear grade estrogen receptor and progesterone receptor their value alone or in combination as indicators of outcome following adjuvant therapy for breast cancer

Schnoy N.; Leistenschneider W., 1982: Tumor of meso nephric origin in a diverticulum of the urethra an ultrastructural study

Mandard A.M.; Marnay J.; Herlin P.; Elie H.; Tuyns A.J.; Le Talaer J.Y., 1984: Tumor of the esophagus induced in wistar rats by oral administration of ethyl n butylnitrosamine

Gariboldi L.M.; Pelizza A.; Villani L.G.; Banchini E., 1986: Tumor of the glomus caroticum diagnostic and therapeutic approach

Andreson J.L.; Banks P.A., 1982: Tumor of the ileo cecal region differentiation from crohns disease

Brama I.; Goldfarb A.; Shalev O.; Ariel I., 1982: Tumor of the nose as a presenting feature of leukemia

Horvath T.J.; Biedermann H.; Schindler A.E., 1980: Tumor of the ovary after hysterectomy

Vetvik K.; Odegaard S.; Schrumpf E.; Arnesjo B., 1985: Tumor of the papilla of vater

Kawabori S.; Et Al, 1981: Tumor of the parotid gland pre operative diagnosis

Huang X.; Yu J.; Zhu X., 1986: Tumor of the penis analysis of 300 cases

Mineur P.; Goffinet S.; Ferrant A.; Bonbled F.; Michaux J.L., 1985: Tumor of the right atrium revealing a hepatocellular carcinoma

Bailey, I. C.; Templeton, A. C., 1976: Tumor of the sciatic nerve

Mukada T.; Andoh N.; Sasano N., 1981: Tumor of the testis an attempt of histological classification according to who guide line

Zachwiej J.; Witeska A.; Piaszczynski J., 1981: Tumor of the urinary bladder preceded by vesical leukoplakia

Kaiserling E.; Geerts M.L., 1986: Tumor of wagner meissner touch corpuscles wagner meissner neurilemoma

Dreghorn C.R., 1988: Tumor or infection misleading spinal radiographs

Mueller Kiesser W.; Vaupel P.; Manz R., 1983: Tumor oxygenation under normobaric and hyperbaric conditions

Gatenby R.A.; Brown T.R., 1987: Tumor oxygenation using direct injection of oxygenated saline

Zhengang, G.; Savaraj, N.; Feun, L. G.; Lu, K.; Stewart, D. J.; Luna, M.; Benjamin, R. S.; Loo, T. L., 1983: Tumor penetration of 4' 9 acridinylamino methanesulfon m anisidide in man

Paskins Hurlburt A.J.; Hollenberg N.K.; Abrams H.L., 1982: Tumor perfusion in relation to the rapid growth phase and necrosis studies on the walker carcinoma in the rat testicle

Stenback, F., 1978: Tumor persistence and regression in skin carcinogenesis an experimental study

Sobel, S.; Rubin, P.; Keller, B.; Poulter, C., 1976: Tumor persistence as a predictor of outcome after radiation therapy of head and neck cancers

Van Den Berg A.P.; Wike Hooley J.L.; Van Den Berg Blok A.E.; Vna Der Zee J.; Reinhold H.S., 1982: Tumor ph in human mammary carcinoma

Osinsky S.; Bubnovskaja L.; Sergienko T., 1987: Tumor ph under induced hyperglycemia and efficacy of chemotherapy

Becker F.F., 1985: Tumor phenotype and susceptibility to progression as an expression of subpopulations of initiated murine cells

D'elia R.O.; Lopez S.; Locatti M.E.; Capozzoli S., 1981: Tumor phyllodes an experience

Rodenburg C.J.; Cornelisse C.J.; Heintz P.A.M.; Hermans J.; Fleuren G.J., 1987: Tumor ploidy as a major prognostic factor in advanced ovarian cancer

Luedecke D.K.; Beck Bornholdt H P.; Saeger W.; Schmidt W., 1985: Tumor ploidy in dna histograms of pituitary adenomas

Kohl F V.; Rudiger H.W., 1979: Tumor prevention by vitamin a in vitro studies with human cultured fibroblasts

Braun Falco O.; Galosi A.; Dorn M.; Plewig G., 1982: Tumor prevention in xeroderma pigmentosum with aromatic retinoid ro 10 9359

Patraseu I.V.; Mihailescu D.; Sandu I.; Coman T.; Stiube P.; Contantinescu E., 1980: Tumor processes in the prostate gland of breeding bulls

Ishizaki R., 1984: Tumor producibility in mice inoculated with y 73 avian sarcoma virus

Mannisto P.T.; Vaissi L.; Mustakallio K.K.; Viluksela M.; Kosma V M.; Collan Y., 1984: Tumor producing activity of dithranol anthralin and 2 of its 10 acyl analogs in the dorsal skin of female nmri mice

Viluksela M.; Puotunen E.; Newman A.J.; Mannisto P.T., 1986: Tumor producing and skin irritating activity of dithranol anthralin and its 10 acyl analogues in sencar mice

Macnab J.C.M., 1979: Tumor production by herpes simplex virus type 2 transformed lines in rats and the varying response to immuno suppression

Wang C.Y.; Croft W.A.; Bryan G.T., 1984: Tumor production in germ free rats fed 5 nitro furans

Brueggen J.; Fogh J.; Sorg C., 1981: Tumor production in the nude mouse fibrinolytic activity and cross reactivity with anti melanoma sera of various human tumor cell lines

Pfeffer, J. M.; Stovin, P. G. I., 1978: Tumor production of alkaline phosphatase in a patient with giant cell carcinoma of bronchus/

Richardson, R. L.; Greco, F. A.; Oldham, R. K.; Liddle, G. W., 1978: Tumor products and potential markers in small cell lung cancer

Artemov, A. V., 1978: Tumor progression

Fainshtein F.E.; Polyanskaya A.M., 1984: Tumor progression associated with chronic lympholeukemia

Holzmann B.; Brocker E.B.; Lehmann J.M.; Ruiter D.J.; Sorg C.; Riethmueller G.; Johnson J.P., 1987: Tumor progression in human malignant melanoma five stages defined by their antigenic phenotypes

Cuypers H.T.M.; Selten G.C.; Zijlstra M.; De Goede R.E.; Melief C.J.; Berns A.J., 1986: Tumor progression in murine leukemia virus induced t cell lymphomas monitoring clonal selections with viral and cellular probes

Rubin H.; Arnstein P.; Chu B.M., 1986: Tumor progression in nude mice and its representation in cell culture

Pollack A.; Block N.L.; Stover B.J.; Irvin G.L.IIi, 1985: Tumor progression in serial passages of the dunning r 3327 g rat prostatic adenocarcinoma growth rate response to endocrine manipulation

Chow D.A.; Chan J., 1987: Tumor progression in vitro the paradoxical natural antibody and complement selected phenotype

Ghanta V.K.; Shrestha I.; Durant J.R.; Hiramoto R.N., 1983: Tumor proliferation and chemo therapy in immuno suppressed mice

Fuerstenberger G.; Marks F., 1979: Tumor promoter 12 o tetra decanoyl phorbol 13 acetate is not a prostaglandin e type agonist

Kinzel V.; Richards J.; Stoehr M., 1980: Tumor promoter 12 o tetra decanoyl phorbol 13 acetate mimics irradiation effects on the cell cycle of hela cells

Lan Tran P.; Ter Minassian Saraga L.; Madelmont G.; Castagna M., 1983: Tumor promoter 12 o tetradecanoyl phorbol 13 acetate alters state fluidity and hydration of 1 2 di acyl sn glycero 3 phospho choline bi layers

Yamamoto N.; Mitsuma T.; Vogt A., 1982: Tumor promoter 12 o tetradecanoyl phorbol 13 acetate effect on complement and epstein barr virus receptors in human lympho blastoid cell lines

Dzarlieva R.T.; Fusenig N.E., 1982: Tumor promoter 12 o tetradecanoyl phorbol 13 acetate enhances sister chromatid exchanges and numerical and structural chromosome aberrations in primary mouse epidermal cell cultures

Yamamoto S.; Nakadate T.; Nakaki T.; Ishii K.; Kato R., 1982: Tumor promoter 12 o tetradecanoyl phorbol 13 acetate induced insulin secretion inhibition by phospho lipase a 2 inhibitors and lip oxygenase inhibitors

Taketani Y.; Oka T., 1983: Tumor promoter 12 o tetradecanoyl phorbol 13 acetate like epidermal growth factor stimulates cell proliferation and inhibits differentiation of mouse mammary epithelial cells in culture

Sim F.R.P.; Salomon D.S.; Nylen M.U.; Pratt R.M., 1981: Tumor promoter 12 o tetradecanoyl phorbol 13 acetate mimics epidermal growth factor induced precocious tooth eruption in the rodent

Nomura S.; Shobu N.; Oishi M., 1983: Tumor promoter 12 o tetradecanoyl phorbol 13 acetate stimulates sv 40 induction by dna damaging agents and tumor initiators

Takasu N.; Shimizu Y.; Yamada T., 1987: Tumor promoter 12 o tetradecanoylphorbol 13 acetate and epidermal growth factor stimulate proliferation and inhibit differentiation of porcine thyroid cells in primary culture

Harada S.; Koyanagi Y.; Nakashima H.; Kobayashi N.; Yamamoto N., 1986: Tumor promoter 12 o tetradecanoylphorbol 13 acetate enhances replication of human t lymphotropic virus type iii lymphadenopathy associated virus

Dzarlieva Petrusevska R.T.; Fusenig N.E., 1985: Tumor promoter 12 o tetradecanoylphorbol 13 acetate induced chromosome aberrations in mouse keratinocyte cell lines a possible genetic mechanism of tumor promotion

Verma A.K.; Bryan G.T.; Reznikoff C.A., 1985: Tumor promoter 12 o tetradecanoylphorbol 13 acetate receptors in normal human transitional epithelial cells

Mechali M.; Mechali F.; Laskey R.A., 1983: Tumor promoter 4 phorbol 12 myristate 13 acetate increases initiation of replication on dna injected into xenopus laevis eggs

Huber B.E.; Brown N.A., 1983: Tumor promoter actions on rat embryonic development in culture

Akiyama T.; Saito T.; Ogawara H.; Toyoshima K.; Yamamoto T., 1988: Tumor promoter and epidermal growth factor stimulate phosphorylation of the c erb b 2 gene product in mkn 7 human adenocarcinoma cells

Jarvinen M.; Ylanne J.; Vartio T.; Virtanen I., 1987: Tumor promoter and fibronectin induce actin stress fibers and focal adhesion sites in spreading human erythroleukemia hel cells

Sonnenberg A.; Dulbecco R.; Okada S., 1983: Tumor promoter binding to rat mammary cell cultures role of receptors in the inhibition of dome formation

Roghani M.; Da Silva C.; Castagna M., 1987: Tumor promoter chloroform is a potent protein kinase c activator

Kaneshima H.; Hiai H.; Fujiki H.; Oguro Y.B.; Lijima S.; Sugimura T.; Nishizuka Y., 1983: Tumor promoter dependent mouse leukemia cell line

Eide B.L.; Krebs E.G.; Ross R.; Pike L.J.; Bowen Pope D.F., 1986: Tumor promoter enhances mitogenesis by platelet derived growth factor binding

Yamasaki H.; Weinstein I.B.; Fibach E.; Rifkind R.A.; Marks P.A., 1979: Tumor promoter induced adhesion of the ds 19 clone of murine erythro leukemia cells

Schliwa M.; Pryzwansky K.B.; Borisy G.G., 1983: Tumor promoter induced centrosome splitting in human polymorphonuclear leukocytes

Ojakian G.K., 1981: Tumor promoter induced changes in the permeability of epithelial cell tight junctions

Ben Ze'ev A., 1986: Tumor promoter induced disruption of junctional complexes in cultured epithelial cells is followed by the inhibition of cytokeratin and desmoplakin synthesis

Lockyer J.M.; Bowden G.T.; Matrisian L.M.; Magun B.E., 1981: Tumor promoter induced inhibition of epidermal growth factor binding to cultured mouse primary epidermal cells

Gopalakrishna R.; Barsky S.H., 1988: Tumor promoter induced membrane bound protein kinase c regulates hematogenous metastasis

Takigawa M.; Simsiman R.C.; Boutwell R.K., 1986: Tumor promoter induced refractory state against ornithine decarboxylase induction by 12 o tetradecanoylphorbol 13 acetate in mouse epidermis

Kopelovich L.; Bias N.E., 1980: Tumor promoter induces loss of anchorage dependence in human skin fibroblasts from individuals genetically predisposed to cancer

Dicker P.; Rozengurt E., 1980: Tumor promoter induces proliferation of 3t6 cells in serum free medium as do poly peptide growth factors

Sobue K.; Fujio Y.; Kanda K., 1988: Tumor promoter induces reorganization of actin filaments and calspectin fodrin or nonerythroid spectrin in 3t3 cells

Kinsella, A. R.; Radman, M., 1978: Tumor promoter induces sister chromatid exchanges relevance to mechanisms of carcinogenesis

Tippetts M.T.; Varnum B.C.; Lim R.W.; Herschman H.R., 1988: Tumor promoter inducible genes are differentially expressed in the developing mouse

Zeggari M.; Susini C.; Viguerie N.; Esteve J.P.; Vaysse N.; Ribet A., 1985: Tumor promoter inhibition of cellular binding of somatostatin

Guy G.R.; Tapley P.M.; Murray A.W., 1981: Tumor promoter inhibition of inter cellular communication between cultured mammalian cells

Fibach E.; Gambari R.; Shaw P.A.; Maniatis G.; Reuben R.C.; Sassa S.; Rifkind R.A.; Marks P.A., 1979: Tumor promoter mediated inhibition of cell differentiation suppression of the expression of erythroid functions in murine erythro leukemia cells

Yamasaki H.; Enomoto T.; Martel N.; Shiba Y.; Kanno Y., 1983: Tumor promoter mediated reversible inhibition of cell cell communication electrical coupling relationship with phorbol ester binding and de novo macro molecule synthesis

Chandler C.E.; Herschman H.R., 1980: Tumor promoter modulation of epidermal growth factor induced and nerve growth factor induced adhesion and growth factor binding of pc 12 pheo chromo cytoma cells

Emerit I.; Cerutti P.A., 1982: Tumor promoter phorbol 12 myristate 13 acetate induces a clastogenic factor in human lymphocytes

Svetlova M.P.; Fedortseva R.F.; Tomilin N.V., 1983: Tumor promoter phorbol 12 myristate 13 acetate induces a protein in human lymphocytes which binds satellite dna

Singh N.; Poirier G.; Cerutti P., 1985: Tumor promoter phorbol 12 myristate 13 acetate induces poly adp ribosylation in fibroblasts

Singh N.; Poirier G.; Cerutti P., 1985: Tumor promoter phorbol 12 myristate 13 acetate induces poly adp ribosylation in human monocytes

Vicentini L.M.; Di Virgilio F.; Ambrosini A.; Pozzan T.; Meldolesi J., 1985: Tumor promoter phorbol 12 myristate 13 acetate inhibits phosphoinositide hydrolysis and cytosolic calcium rise induced by the activation of muscarinic receptors in pc 12 cells

Belin D.; Godeau F.; Vassalli J D., 1984: Tumor promoter phorbol 12 myristate 13 acetate stimulates the synthesis and secretion of mouse prourokinase in mouse sarcoma virus transformed 3t3 cells this is mediated by an increase in urokinase messenger rna content

Di Virgilio F.; Pozzan T.; Wollheim C.B.; Vicentini L.M.; Meldolesi J., 1986: Tumor promoter phorbol myristate acetate inhibits calcium influx through voltage gated calcium channels in two secretory cell lines pc 12 and rin m 5f

Ralph P.; Kishimoto T., 1982: Tumor promoter phorbol myristic acetate is a t cell dependent inducer of immuno globulin secretion in human lymphocytes

Ralph P.; Kishimoto T., 1981: Tumor promoter phorbol myristic acetate stimulates immuno globulin secretion correlated with growth cessation in human b lymphocyte cell lines

Colburn N.H., 1980: Tumor promoter produces anchorage independence in mouse epidermal cells by an induction mechanism

Spinelli W.; Ishii D.N., 1983: Tumor promoter receptors regulating neurite formation in cultured human neuro blastoma cells

Srinivas L.; Gindhart T.D.; Colburn N.H., 1982: Tumor promoter resistant cells lack tri sialo ganglioside response

Takanaka K.; O'brien P.J.; Tsuruta Y.; Rahimtula A.D., 1982: Tumor promoter stimulated irreversible binding of n methylamino azo benzene to polymorphonuclear leukocyte dna

Edinger F.M.; Penn A., 1985: Tumor promoter stimulated protein phosphorylation in mouse epidermis is inhibited by bromophenacyl bromide

Wunderlich V.; Baumbach L.; Sydow G., 1982: Tumor promoter stimulated synthesis of mason pfizer monkey virus

Kitagawa K.; Nishino H.; Iwashima A. , 1985: Tumor promoter stimulated translocation of glucose transport system in mouse embryo fibroblast swiss 3t3 cell

Guy G.R.; Murray A.W., 1982: Tumor promoter stimulation of phosphatidyl choline turnover in hela cells

Laszlo A.; Radke K.; Chin S.; Bissell M.J., 1981: Tumor promoters alter gene expression and protein phosphorylation in avian cells in culture

Fisher P.B.; Young C.S.H.; Weinstein I.B.; Carter T.H., 1981: Tumor promoters alter the temporal program of adenovirus replication in human cells

Lau A.F.; Rayson T.C.; Humphreys T., 1986: Tumor promoters and diacylglycerol activate the sodium proton antiporter of sea urchin eggs

Fisher P.B.; Bozzone J.H.; Weinstein I.B., 1979: Tumor promoters and epidermal growth factor stimulate anchorage independent growth of adenovirus transformed rat embryo cells

Gottesman M.M.; Sobel M.E., 1980: Tumor promoters and kirsten sarcoma virus increase synthesis of a secreted glyco protein by regulating levels of translatable messenger rna

Mockel J.; Van Sande J.; Decoster C.; Dumont J.E., 1987: Tumor promoters as probes of protein kinase c in dog thyroid cell inhibition of the primary effects of carbamylcholine and reproduction of some distal effects

Friedman B.; Frackelton A.R.Jr; Ross A.H.; Connors J.M.; Fujiki H.; Sugimura T.; Rosner M.R., 1984: Tumor promoters block tyrosine specific phosphorylation of the epidermal growth factor receptor

Enomoto T.; Sasaki Y.; Shiba Y.; Kanno Y.; Yamasaki H., 1981: Tumor promoters cause a rapid and reversible inhibition of the formation and maintenance of electrical cell coupling in culture

Casnellie J.E.; Lamberts R.J., 1986: Tumor promoters cause changes in the state of phosphorylation and apparent molecular weight of a tyrosine protein kinase in t lymphocytes

Diamond, L.; O'brien, T. G.; Rovera, G., 1978: Tumor promoters effects on proliferation and differentiation of cells in culture

Cronin M.J.; Canonico P.L., 1985: Tumor promoters enhance basal and growth hormone releasing factor stimulated cyclic amp levels in anterior pituitary cells

Cherif Zahar C.; Vaigot P.; Castagna M., 1983: Tumor promoters enhance cap formation in mouse thymocytes

Fibach E.; Marks P.A.; Rifkind R.A., 1980: Tumor promoters enhance myeloid and erythroid colony formation by normal mouse hemopoietic cells

Isakov N.; Altman A., 1985: Tumor promoters in conjunction with calcium ionophores mimic antigenic stimulation by reactivation of alloantigen primed murine t lymphocytes

Hiwasa T.; Fujimura S.; Sakiyama S., 1982: Tumor promoters increase the synthesis of a 32 kilodalton protein in balb c 3t3 cells

Fey E.G.; Penman S., 1984: Tumor promoters induce a specific morphological signature in the nuclear matrix intermediate filament scaffold of madin darby canine kidney cell colonies

Rifkin D.B.; Crowe R.M.; Pollack R., 1979: Tumor promoters induce changes in the chick embryo fibroblast cytoskeleton

Fibach E.; Rachmilewitz E.A., 1981: Tumor promoters induce macrophage differentiation in human myeloid cells from patients with acute and chronic myelogenous leukemia

Fisher P.B.; Flamm M.; Schachter D.; Weinstein I.B., 1979: Tumor promoters induce membrane changes detected by fluorescence polarization

Gottesman M.M.; Yuspa S.H., 1981: Tumor promoters induce synthesis of a secreted glyco protein in mouse skin and cultured primary mouse epidermal cells

Murray A.W.; Fitzgerald D.J., 1979: Tumor promoters inhibit metabolic cooperation in co cultures of epidermal and 3t3 cells

Ishii, D. N.; Fibach, E.; Yamasaki, H.; Weinstein, I. B., 1978: Tumor promoters inhibit morphological differentiation in cultured mouse neuro blastoma cells

Yamasaki, H.; Fibach, E.; Nudel, U.; Weinstein, I. B.; Rifkind, R. A.; Marks, P. A., 1977: Tumor promoters inhibit spontaneous and induced differentiation of murine erythro leukemia cells in culture

Rovera, G.; O'brien, T. G.; Diamond, L., 1977: Tumor promoters inhibit spontaneous differentiation of friend erythro leukemia cells in culture

Yamagishi H.; Kunisada T.; Toda M.; Ohnishi N.; Fujiki H.; Sekiguchi T., 1984: Tumor promoters may induce the appearance of extrachromosomal circular dna species in rodent cell lines

Miwa J.; Tabuse Y.; Furusawa M.; Yamasaki H., 1982: Tumor promoters specifically and reversibly disturb development and behavior of caenorhabditis elegans

Mascardo R.N.; Sherline P., 1984: Tumor promoters stimulate hyperplasia of microtubule organizing center and inhibit dna synthesis in cultured cells

Digiovanni J.; Boutwell R.K., 1983: Tumor promoting activity of 1 8 di hydroxy 3 methyl 9 anthrone chrysarobin in female sencar mice

Diwan B.A.; Rice J.M.; Ward J.M., 1986: Tumor promoting activity of benzodiazepine tranquilizers diazepam and oxazepam in mouse liver

Chortyk, O. T.; Bock, F. G., 1976: Tumor promoting activity of certain extracts of tobacco

Upadhyay R.R.; Sater A.M.; Moinzadeh F.; Bunakdari A.; Sedehi F.; Samin R., 1984: Tumor promoting activity of euphorbia striatella and skin irritant activity of some euphorbia species

Tokuda H.; Ito Y.; Kanaoka T.; Yoshida O., 1987: Tumor promoting activity of extracts of human semen in sencar mice

Suganuma M.; Fujiki H.; Morino K.; Takayama S.; Sugimura T., 1987: Tumor promoting activity of teleocidin in skin and forestomach of mice initiated transplacentally with 7 12 dimethylbenz a anthracene

Sundar S.K.; Ablashi D.V.; Levine P.H.; Wallen W.C.; Armstrong G.R., 1981: Tumor promoting agent induces lymphocyte mitogenic factor

Edwards M.C.; Nouri A.M.E.; Gordon D.; Evans F.J., 1983: Tumor promoting and nonpromoting pro inflammatory esters act as human lymphocyte mitogens with different sensitivities to inhibition by cyclosporin a

Althaus F.R.; Eichenberger R.; Pitot H.C., 1986: Tumor promoting barbiturates act on dna repair of cultured hepatocytes

Keller R.; Keist R.; Adolf W.; Opferkuch H.J.; Schmidt R.; Hecker E., 1982: Tumor promoting di terpene esters prevent macrophage activation and suppress macrophage tumoricidal capacity

Agrawal R.C.; Wiessler M.; Hecker E.; Bhide S.V., 1986: Tumor promoting effect of chilli extract in balb c mice

Sun Y.; Chen M.; Xiao H.; Liu H.; Chen X.; Zeng Y.; Ito Y., 1987: Tumor promoting effect of diterpene ester hhpa and extract of wikstroemia chamaedaphne on hsv 2 induced carcinoma in mice

Diwan B.A.; Ward J.M.; Rice J.M.; Colburn N.H.; Spangler E.F., 1985: Tumor promoting effects of di 2 ethylhexylphthalate in jb 6 mouse epidermal cells and mouse skin

Segal, A.; Van-Duuren, B. L.; Mate, U.; Solomon, J. J.; Seidman, I.; Smith, A.; Melchionne, S., 1978: Tumor promoting of 2 3 di hydro phorbol myristate acetate and phorbolol myristate acetate in mouse skin

Fukuda M., 1981: Tumor promoting phorbol di ester induced specific changes in cell surface glyco protein profile of k 562 human leukemic cells

Castagna M.; Rochette Egly C.; Rosenfeld C., 1979: Tumor promoting phorbol di ester induces substrate adhesion and growth inhibition in lympho blastoid cells

Castagna M.; Yagello M.; Rabourdin Combe C.; Fridman W.H., 1980: Tumor promoting phorbol di esters inhibit in vitro antibody synthesis

Davis R.J.; Czech M.P., 1984: Tumor promoting phorbol di esters mediate phosphorylation of the epidermal growth factor receptor

Montz H.P.M.; Davis G.E.; Skaper S.D.; Manthorpe M.; Varon S., 1985: Tumor promoting phorbol diester mimics two distinct neuronotrophic factors

Davis R.J.; Czech M.P., 1985: Tumor promoting phorbol diesters cause the phosphorylation of epidermal growth factor receptors in normal human fibroblasts at threonine 654

Cabot M.C., 1984: Tumor promoting phorbol diesters substrates for diacylglycerol lipase

Kido H.; Fukusen N.; Katunuma N., 1987: Tumor promoting phorbol ester amplifies the inductions of tyrosine aminotransferase and ornithine decarboxylase by glucocorticoid

Byus, C. V.; Weiner, R. A., 1982: Tumor promoting phorbol ester derivatives increase ornithine decarboxylase ec activity and poly amine biosynthesis in the liver of the rat and mouse

Kohno H.; Takatani S.; Tokunaga R., 1985: Tumor promoting phorbol ester induced phosphorylation of cell surface transferrin receptors in human erythroleukemia cells

Grunberger G.; Zick Y.; Taylor S.I.; Gorden P., 1984: Tumor promoting phorbol ester stimulates tyrosine phosphorylation in u 937 monocytes

Osborne R.; Tashjian A.H.Jr, 1981: Tumor promoting phorbol esters affect production of prolactin and growth hormone by rat pituitary cells

Salo T.; Turpeenniemi Hujanen T.; Tryggvason K., 1985: Tumor promoting phorbol esters and cell proliferation stimulate secretion of basement membrane type iv collagen degrading metalloproteinase by human fibroblasts

Shiba Y., 1982: Tumor promoting phorbol esters and mezerein induce contraction in hydra hydra japonica

Madshus I.H.; Sandvig K.; Olsnes S., 1985: Tumor promoting phorbol esters and vanadate alter the sensitivity of hela s 3 cells to poliovirus type 1

Marian B., 1987: Tumor promoting phorbol esters cause a stable reduction of dermal collagen in mouse skin

Van De Werve G.; Proietto J.; Jeanrenaud B., 1985: Tumor promoting phorbol esters increase basal and inhibit insulin stimulated lipogenesis in rat adipocytes without decreasing insulin binding

Haring H.; Kirsch D.; Obermaier B.; Ermel B.; Machicao F., 1986: Tumor promoting phorbol esters increase the michaelis constant of the atp binding site of the insulin receptor kinase from rat adipocytes

Montesano R.; Orci L., 1985: Tumor promoting phorbol esters induce angiogenesis in vitro

Morris P.B.; Hida T.; Blackshear P.J.; Klintworth G.K.; Swain J.L., 1988: Tumor promoting phorbol esters induce angiogenesis in vivo

Keller R.; Keist R., 1982: Tumor promoting phorbol esters induce macrophage differentiation from bone marrow precursors

Mueller W.A., 1985: Tumor promoting phorbol esters induce metamorphosis and multiple head formation in the hydroid hydractinia echinata

O'shea J.J.; Brown E.J.; Gaither T.A.; Takahashi T.; Frank M.M., 1985: Tumor promoting phorbol esters induce rapid internalization of the complement c 3b receptor via a cytoskeleton dependent mechanism

Lee, L. S.; Weinstein, I. B., 1978: Tumor promoting phorbol esters inhibit binding of epidermal growth factor to cellular receptors

Yuan S.; Sunahara F.A.; Sen A.K., 1987: Tumor promoting phorbol esters inhibit cardiac functions and induce redistribution of protein kinase c in perfused beating rat heart

Chen B.D M.; Lin H S.; Hsu S., 1983: Tumor promoting phorbol esters inhibit the binding of colony stimulating factor to murine peritoneal exudate macrophages

Escudero F.; Carmena M.J.; Prieto J.C., 1987: Tumor promoting phorbol esters interfere with the vasoactive intestinal peptide receptor effector system in rat prostatic epithelial cells

Sieber Blum M.; Sieber F., 1981: Tumor promoting phorbol esters promote melanogenesis and prevent expression of the adrenergic phenotype in quail coturnix coturnix japonica neural crest cells

Shiba Y.; Yamasaki H.; Kanno Y., 1987: Tumor promoting phorbol esters rapidly inhibit bud formation in hydra

Solbach W., 1982: Tumor promoting phorbol esters selectively abrogate the expression of the t 4 differentiation antigen expressed on normal and malignant sezary t helper lymphocytes

Wright, S. D.; Silverstein, S. C., 1982: Tumor promoting phorbol esters stimulate complement c 3b and complement c 3b' receptor mediated phagocytosis in cultured human monocytes

Sieber F.; Stuart R.K.; Spivak J.L., 1981: Tumor promoting phorbol esters stimulate myelopoiesis and suppress erythropoiesis in cultures of mouse bone marrow cells

Trevillyan J.M.; Kulharni R.K.; Byus C.V., 1984: Tumor promoting phorbol esters stimulate the phosphorylation of ribosomal protein s 6 in quiescent reuber h 35 hepatoma cells

Bijsterbosch M.K.; Klaus G.G.B., 1987: Tumor promoting phorbol esters suppress receptor stimulated inositol phospholipid degradation and calcium mobilization in mouse lymphocytes

Clark-Lewis, I.; Murray, A. W., 1978: Tumor promotion and the induction of epidermal ornithine decarboxylase activity in mechanically stimulated mouse skin

Argyris T.S., 1980: Tumor promotion by abrasion induced epidermal hyperplasia in the skin of mice

Reddy B.S.; Maeura Y., 1984: Tumor promotion by dietary fat in azoxy methane induced colon carcinogenesis in female f 344 rats influence of amount and source of dietary fat

Ryan W.L.; Stenback F.; Curtis G.L., 1981: Tumor promotion by foreign bodies intra uterine devices

Fuerstenberger G.; Sorg B.; Marks F., 1983: Tumor promotion by phorbol esters in skin evidence for a memory effect

Flodstrom S.; Warngard L.; Hemming H.; Fransson R.; Ahlborg U.G., 1988: Tumor promotion related effects by the cyclodiene insecticide endosulfan studied in vitro and in vivo

Tomita K., 1985: Tumor prosthesis for limb salvage in malignant bone tumor of the extremities

Jaeger M.; Loeffler L.; Kohn D., 1985: Tumor prosthesis of the hip joint indications and results

Yamagishi H.; Pellis N.R.; Kahan B.D., 1979: Tumor protective and tumor facilitating antigens from 3 molar potassium chloride solubilized tumor extracts

Menard S.; Miotti S.; Tagliabue E.; Parmi L.; Buraggi G.L.; Colnaghi M.I., 1983: Tumor radio immuno localization in a murine system using mono clonal antibodies

Ballou B.; Jaffe R.; Taylor R.J.; Solter D.; Hakala T.R., 1984: Tumor radio immuno location differential antibody retention by antigenic normal tissue and tumor

Evans R.G., 1985: Tumor radiosensitization with concomitant bone marrow radioprotection a study in mice using diethyldithiocarbamate under oxygenated and hypoxic conditions

Yamaura H.; Matsuzawa T., 1979: Tumor re growth after irradiation an experimental approach

Clement, J. J.; Tanaka, N.; Song, C. W., 1978: Tumor re oxygenation and post irradiation vascular changes

Shingleton H.M.; Gore H.; Soong S J.; Orr J.W.Jr; Hatch K.D.; Austin J.M.Jr; Partridge E.E., 1983: Tumor recurrence and survival in stage ib cancer of the cervix

Hughes E.S.R.; Mcdermott F.T.; Polglase A.L.; Johnson W.R., 1983: Tumor recurrence in the abdominal wall scar tissue after large bowel cancer surgery

Ebner, F.; Kressel, H. Y.; Mintz, M. C.; Carlson, J. A.; Cohen, E. K.; Schiebler, M.; Gefter, W.; Axel, L., 1988: Tumor recurrence versus fibrosis in the female pelvis differentiation with mr imaging at 1.5 t

Hakansson L.; Jonsson S.; Soderberg M.; Enestrom S.; Lieden G.; Lindgren S., 1984: Tumor regression after extracorporeal affinity chromatography of blood plasma across agarose beads containing staphylococcal protein

Yarkoni, E.; Meltzer, M. S.; Rapp, H. J., 1977: Tumor regression after intra lesional injection of emulsified trehalose 6 6 di mycolate cord factor efficacy increases with oil concentration

Yarkoni E.; Rapp H.J., 1979: Tumor regression after intra lesional injection of mycobacterial components emulsified in 2 6 10 15 19 23 hexa methyl 2 6 10 14 18 22 tetracosahexaene squalene 2 6 10 15 19 23 hexa methyl tetracosane squalane peanut oil or mineral oil

Pizza G.; Severini G.; Menniti D.; De Vinci C.; Corrado F., 1984: Tumor regression after intralesional injection of interleukin 2 in bladder cancer preliminary report

Shukla M.; Gerke E.; Bornfeld N.; Meyer Schwickerath G., 1987: Tumor regression after photocoagulation of malignant melanomas of the choroid an ultrasonographic study

Maruyama Y.; Yoneda J.; Van Nagell J.R.; Donaldson E.S.; Hanson M.; Powell D.; Muir W., 1982: Tumor regression and histologic clearance after neutron brachy therapy for bulky localized cervical carcinoma

Fazekas J.T.; Sommer C.; Kramer S., 1983: Tumor regression and other prognosticators in advanced head and neck cancers a sequel to the radiation therapy oncology group methotrexate study

Hedley, D. W.; Mcelwain, T. J.; Currie, G. A., 1977: Tumor regression and survival of patients with disseminated malignant melanoma treated with chemo therapy and specific active immuno therapy

Seder R.H.; Vaughan C.W.; Oh S K.; Keggins J.J.; Hayes J.A.; Blanchard G.C.; Vincent M.E.; Katz A.E., 1987: Tumor regression and temporary restoration of immune response after plasmapheresis in a patient with recurrent oral cancer

Dische S.; Bennett M.H.; Saunders M.I.; Anderson P.A., 1980: Tumor regression as a guide to prognosis a clinical study

Denekamp, J., 1977: Tumor regression as a guide to prognosis a study with experimental animals

Schlager, S. I.; Dray, S., 1975: Tumor regression at an untreated site during immuno therapy of an identical distant tumor

Mantyla M.; Kortekangas A.E.; Valavaara; Nordman E.M., 1979: Tumor regression during radiation treatment as a guide to prognosis

Kumagai K.; Yasui A.; Nishida Y.; Izumi T.; Kurihara M., 1988: Tumor regression effect of cancer chemotherapy on depressed types of early gastric carcinoma

King, A. C., 1978: Tumor regression in mice after treatment with extracts of the bone marrow from cattle harboring tick borne infections

Muehlenstedt, D.; Osmers, F.; Schneider, H. P. G., 1978: Tumor regression in pituitary adenoma by bromocriptine

Wiedenmann B.; Raeth U.; Raedsch R.; Becker F.; Kommerell B., 1988: Tumor regression of an ileal carcinoid under the treatment with the somatostatin analogue sms 201 995

Benedict W.F.; Lingua R.W.; Doiron D.R.; Dawson J.A.; Murphree A.L., 1980: Tumor regression of human retino blastoma in the nude mouse following photo radiation therapy a preliminary report

Gabelov A.A.; Zharinov G.M., 1983: Tumor regression rates and effectiveness of radiation treatment of patients with cervical carcinoma

Baldwin, R. W.; Price, M. R., 1977: Tumor rejection antigens associated with carcinogen induced tumors

Srivastava P.K.; Deleo A.B.; Old L.J., 1986: Tumor rejection antigens of chemically induced sarcomas of inbred mice

Kolin A.; Vacek J.; Landi S., 1983: Tumor rejection in immunized guinea pigs

Visintainer M.A.; Volpicelli J.R.; Seligman M.E.P., 1982: Tumor rejection in rats after inescapable or escapable shock

Shah, L. P.; Rees, R. C.; Baldwin, R. W., 1976: Tumor rejection in rats sensitized to embryonic tissue part 1 rejection of tumor cells implanted sub cutaneously and detection of cyto toxic lymphoid cells

Zbar B.; Nagai A.; Terata N.; Hovis J., 1983: Tumor rejection mediated by an amphotropic murine leukemia virus

Embleton M.J.; Baldwin R.W., 1979: Tumor related antigen specificities associated with 3 methyl cholanthrene treated rat embryo cells

Granatek, C. H.; Hersh, E. M.; Gutterman, J. U.; Mavligit, G. M., 1977: Tumor related blocking of anti fetal immunity

Hersey P.; Edwards A.; Mccarthy W.H., 1980: Tumor related changes in natural killer cell activity in melanoma patients influence of stage of disease tumor thickness and age of patients

Hermanowicz A.; Gibson P.R.; Jewell D.P., 1987: Tumor related inhibition of macrophage chemotaxis in patients with colon cancer

Knierim M.; Paweletz N.; Finze E M., 1986: Tumor related reconstitutive vascularization an ultrastructural study

Widder K.J.; Morris R.M.; Poore G.; Howard D.P.Jr; Senyei A.E., 1981: Tumor remission in yoshida sarcoma bearing rats by selective targeting of magnetic albumin microspheres containing doxorubicin

Schoeche J.; Hohrein D.; Wehner W.; Mueller W.; Neumann A.; Fritsch G.; Fuessel J., 1986: Tumor removal by ultrasound report on 50 cerebral tumor operations

Carli M.; Pastore G.; Perilongo G.; Grotto P.; De Bernardi B.; Ceci A.; Di Tullio M.; Madon E.; Pianca C.; Paolucci G., 1988: Tumor response and toxicity after single high dose versus standard five day divided dose dactinomycin in childhood rhabdomyosarcoma

Luk C.K.; Tannock I.F., 1988: Tumor response to chemotherapy in animals that have been treated with the same drugs prior to tumor implantation a model for studying host effects on apparent drug resistance

Arcangeli G.; Arcangeli G.; Guerra A.; Lovisolo G.; Cividalli A.; Marino C.; Mauro F., 1985: Tumor response to heat and radiation prognostic variables in the treatment of neck node metastases from head and neck cancer

Hiraoka M.; Akuta K.; Nishimura Y.; Nagata Y.; Jo S.; Takahashi M.; Abe M., 1987: Tumor response to thermoradiation therapy use of ct in evaluation

Meyer J.L.; Van Kersen I.; Hahn G.M., 1986: Tumor responses following multiple hyperthermia and x ray treatments role of thermotolerance at the cellular level

Ozeki, M.; Furukawa, Y.; Kono, A.; Yano, K., 1977: Tumor scintigram with 201 t 1

Henze, E.; Kuebel, R.; Waitzinger, J.; Buechler, M.; Adam, W. E.; Beger, H. G., 1987: Tumor scintigraphy with iodine 131 anti cea monoclonal antibodies and fab' 2 in colorectal cancer

Chow D.A., 1984: Tumor selection in vivo for reduced sensitized to natural resistance and natural antibodies

Mareel M.; Dragonetti C.; Tavernier J.; Fiers W., 1988: Tumor selective cytotoxic effects of murine tumor necrosis factor tnf and interferon gamma ifn gamma in organ culture of b16 melanoma cells and heart tissue

Chaney J.E.; Kobayashi K.; Goto R.; Digenis G.A., 1983: Tumor selective enhancement of radioactivity uptake in mice treated with alpha di fluoromethyl ornithine prior to administration of carbon 14 labeled putrescine

Boothman, D.; Briggle, T. V.; Greer, S., 1987: Tumor selective metabolism of 5 fluoro 2' deoxycytidine coadministered with tetrahydrouridine compared to 5 fluorouracil in mice bearing lewis lung carcinoma

Jaehde E.; Rajewsky M.F., 1982: Tumor selective modification of cellular micro environment in vivo effect of glucose infusion on the ph in normal and malignant rat tissues

Laursen M.L.; Laursen K., 1979: Tumor sensitization obtained by injection of antigenic tumor cells into the cecal lumen of syngeneic mice

Grdina D.J.; Thames H.D.; Milas L., 1984: Tumor sensitizing effect by misonidazole in a clinically relevant radiation dose range

Dvorak H.F.; Quay S.C.; Orenstein N.S.; Dvorak A.M.; Hahn P.; Bitzer A.M.; Carvalho A.C., 1981: Tumor shedding and coagulation

Supe S.J.; Nagalaxmi K.V.; Meenaksi L., 1983: Tumor significant dose

Elbers H.; Stadt J.V.D.; Wagenaar S.S., 1980: Tumor simulating thoracic extramedullary hematopoiesis

Halvorsen T.B.; Seim E., 1987: Tumor site a prognostic factor in colorectal cancer a multivariate analysis

Biggar R.J.; Nkrumah F.K., 1979: Tumor site and renal dys function as factors influencing leukopenia after chemo therapy for burkitts lymphoma

Baltzer J.; Koepcke W., 1979: Tumor size and lymph node metastases in squamous cell carcinoma of the uterine cervix

Wolmark N.; Cruz I.; Redmond C.K.; Fisher B.; Fisherd E.R., 1983: Tumor size and regional lymph node metastasis in colo rectal cancer a preliminary analysis from the national surgical adjuvant breast and bowel project clinical trials

Soorae, A. S.; Smith, R. A., 1977: Tumor size as a prognostic factor after resection of lung carcinoma

Okunieff P.G.; Koutcher J.A.; Gerweck L.; Mcfarland E.; Hitzig B.; Urano M.; Brady T.; Neuringer L.; Suit H.D., 1986: Tumor size dependent changes in a murine fibrosarcoma use of in vivo phosphorus 31 nmr for non invasive evaluation of tumor metabolic status

Hagan P.L.; Halpern S.E.; Dillman R.O.; Shawle D.L.; Johnson D.E.; Chen A.; Krishnan L.; Frincke J.; Bartholomew R.M.; Et Al, 1986: Tumor size effect on monoclonal antibody uptake in tumor models

Schink J.C.; Lurain J.R.; Wallemark C.B.; Chmiei J.S., 1987: Tumor size in endometrial cancer a prognostic factor for lymph node metastasis

Harper P.G.; Souhami R.L.; Spiro S.G.; Geddes D.M.; Guimaraes M.; Fearon F.; Smyth J.F., 1982: Tumor size response rate and prognosis in small cell carcinoma of the bronchus treated by combination chemo therapy

Norton, L.; Simon, R., 1977: Tumor size sensitivity to therapy and design of treatment schedules

Comoglio, P. M.; Bertini, M.; Prat, M., 1978: Tumor specific and tumor associated membrane antigens of rous sarcoma virus transformed hamster fibroblasts

Kumar, S.; Waghe, M.; Taylor, G., 1977: Tumor specific antibodies reactive with cell surface antigens in children with wilms tumor

Allison J.P.; Mcintyre B.W.; Bloch D., 1982: Tumor specific antigen of murine t lymphoma defined with mono clonal antibody

Yokota, T.; Sizaret, P.; Martel, N., 1978: Tumor specific antigens on rat liver cells transformed in vitro by chemical carcinogens

Byers, V. S.; Levin, A. S.; Hackett, A. J.; Fudenberg, H. H., 1975: Tumor specific cell mediated immunity in household contacts of cancer patients

Price, M. R.; Baldwin, R. W., 1977: Tumor specific complement dependent serum cyto toxicity against a chemically induced rat hepatoma

Cuatico W.; Cho J R., 1979: Tumor specific dna sequences in human gliomas

Stavrou, D.; Anzil, A. P.; Elling, H., 1978: Tumor specific fluorescent and complement dependent cyto toxic antibodies in the serum of rats with chemically induced brain gliomas

Brown B.A.; Davis G.L.; Saltzgaber Muller J.; Simon P.; Ho M K.; Shaw P.S.; Stone B.A.; Sands H.; Moore G.P., 1987: Tumor specific genetically engineered murine human chimeric monoclonal antibody

Smith D.W.E.; Mcnamara A.L.; Mushinski J.F.; Hatfield D.L., 1985: Tumor specific hypomodified phenylalanyl transfer rna is utilized in translation in preference to the fully modified isoacceptor of normal cells

Kuchroo V.K.; Lee V.K.; Hellstrom I.; Hellstrom K.E.; Halliday W.J., 1987: Tumor specific idiotopes on suppressor factors and suppressor cells revealed by monoclonal anti idiotope antibodies

Raychaudhuri, S.; Saeki, Y.; Fuji, H.; Kohler, H., 1986: Tumor specific idiotype vaccines i. generation and characterization of internal image tumor antigen

Raychaudhuri, S.; Saeki, Y.; Chen, J. J.; Iribe, H.; Fuji, H.; Kohler, H., 1987: Tumor specific idiotype vaccines ii. analysis of the tumor related network response induced by the tumor and by internal image antigens ab2 beta

Raychaudhuri, S.; Saeki, Y.; Chen, J. J.; Kohler, H., 1987: Tumor specific idiotype vaccines iii. induction of t helper cells by anti idiotype and tumor cells

Nakamura S., 1981: Tumor specific immune response evaluated by leukocyte migration inhibition tests under agarose plate in gynecological malignancy

Burk, M. W.; Yu, S.; Mckhann, C. F., 1976: Tumor specific immune responsiveness of the tumor bearing host

Rella, W.; Kotz, R.; Arbes, H.; Leber, H., 1977: Tumor specific immunity in sarcoma patients

Kim, B. S.; Liang, W.; Cohen, E. P., 1979: Tumor specific immunity induced by somatic hybrids 1. lack of relationship between immunogenicity and tumorigenicity of selected hybrids

Kim, B. S., 1979: Tumor specific immunity induced by somatic hybrids 2. elicitation of enhanced immunity against the parent plasma cytoma

Kim, B. S., 1981: Tumor specific immunity induced by somatic hybrids 3. persistence of adoptively transferred immunity specific for tepc 15 plasma cytoma in normal balb c mice

Hui, K. M.; Kim, B. S., 1984: Tumor specific immunity induced by somatic hybrids 4. relationship between immunogenicity and expression of surface tumor associated antigens

Forbes, J. T.; Nakao, Y.; Smith, R. T., 1975: Tumor specific immunity to chemically induced tumors evidence for immunologic specificity and shared antigenicity in lymphocyte responses to soluble tumor antigens

Peter C.R.; Wilson B.J.; Malley A.; Eisenhut D.A.; Hu F., 1979: Tumor specific immunity to mouse melanoma in vitro

Eggers, A. E., 1976: Tumor specific immunogenicity induced by chemical modification

Yamauchi M., 1985: Tumor specific immunoresponse in cancer patients with leukocyte adherence inhibition and leukocyte migration inhibition test

Schaerfe T.; Becht E.; Kaltwasser R.; Thueroff J.W.; Jacobi G.H.; Hohenfellner R., 1985: Tumor specific monoclonal antibodies for renal cell carcinoma

Kuchino, Y.; Borek, E., 1978: Tumor specific phenyl alanine transfer rna contains 2 supernumerary methylated bases

Supowit S.C.; Rosen J.J.M., 1981: Tumor specific poly adenylated rna from 7 12 di methyl benz a anthracene induced mammary tumors revealed through hybridization with fractionated single copy dna

Weese J.L.; Starling J.R.; Syrjala S., 1983: Tumor specific reactivity during development of n methyl n nitroso urea induced rat colon cancer

Kataoka, T.; Kamiyama, T.; Tokunaga, T., 1978: Tumor specific skin reactive antigen solubilized from a syngeneic guinea pig lipo sarcoma by 3 molar potassium chloride

Huber S.A.; Bigi G.; Lucas Z.J., 1980: Tumor specific suppressor cells induced by immunization with spleen cells from tumor bearing animals

Bear H.D., 1986: Tumor specific suppressor t cells which inhibit the in vitro generation of cytolytic t cells from immune and early tumor bearing host spleens

Howie S.; Mcbride W.H., 1982: Tumor specific t helper activity can be abrogated by 2 distinct suppressor cell mechanisms

Lau B.H.S.; Wang Cheng R.M.; Tosk J., 1987: Tumor specific t lymphocyte cytotoxicity enhanced by low dose of corynebacterium parvum

Karjalainen, H. E.; Laaksonen, A. M.; Mantyjarvi, R. A., 1978: Tumor specific transplantation antigen in hamster tumor cells induced with bk virus

Anderson, J. L.; Martin, R. G.; Chang, C.; Mora, P. T., 1977: Tumor specific transplantation antigen is expressed during sv 40 lytic infection with wild type and tsa mutant viruses

Jay, G.; Jay, F. T.; Chang, C.; Friedman, R. M.; Levine, A. S., 1978: Tumor specific transplantation antigen use of the adenovirus 2 sv 40 hybrid virus to identify the protein responsible for sv 40 tumor rejection and its genetic origin

Yaniv, A.; Gotlieb-Stematsky, T.; Eylan, E., 1977: Tumor specific transplantation antigens in spontaneously transformed hamster cell lines

Masuda H., 1987: Tumor specificity of oncogene alteration in human malignant tumors

Chaitchik S.; Asher O.; Deutsch M.; Weinreb A., 1985: Tumor specificity of the structuredness of cytoplasmic matrix test for cancer diagnosis

Fisher, B.; Hanlon, J. T.; Linta, J.; Saffer, E., 1977: Tumor specificity serum inhibition and influence of regional lymph nodes on cyto toxic macrophages from cultured bone marrow

Lynch H.T.; Fusaro R.M.; Pester J.; Oosterhuis J.A.; Went L.N.; Rumke P.; Neering H.; Lynch J.F., 1981: Tumor spectrum in the familial atypical multiple mole melanoma syndrome

Vallera D.A.; Mentzer S.J.; Maizel S.E., 1982: Tumor sponge implantation an in vivo method for studying syngeneic primary anti tumor lymphocyte responses

Ljungberg B.; Stenling R.; Roos G., 1988: Tumor spread and dna content in human renal cell carcinoma

Mueller K M.; Riepert T., 1985: Tumor spreading in lungs with preexisting anthracosilicosis

Storm F.K.; Scanlon E.F.; Baker H.W.; Roe D.; Morton D.L., 1987: Tumor stabilization after hyperthermia an important criterion of response to thermal therapy

Swanson D.L.; Fisher I., 1981: Tumor stage mycosis fungoides a 32 year survival

Groth O.; Molin L.; Thomsen K.; Grunnet E.; Hellbe L.; Holst R.; Michaelsson G.; Nilsson E.; Roupe G.; Et Al, 1979: Tumor stage of mycosis fungoides treated with bleomycin and methotrexate report from the scandinavian mycosis fungoides study group

Roth J.A.; Davidson D.D.; Ames R.S.; Schneider P.D., 1983: Tumor stasis factor a possible mechanism for the regulation of tumor cell proliferation

Ludwig C.; Ludwig R.; Obrecht J.P., 1981: Tumor stem cell cultures on agar 1st results

Skipper H.E.; Schabel F.M.Jr, 1984: Tumor stem cell heterogeneity implications with respect to classification of cancers by chemo therapeutic effect

Yoshii Y.; Maki Y.; Takano S.; Komatsu Y.; Tsurushima H.; Higuchi O.; Yamada Y.; Oohara K.; Kubota S.; Et Al, 1987: Tumor sterilization dose and radiation induced change of the brain tissue in radiotherapy of brain tumors

Stryker J.A.; Chung C.K.; Clement J.A.; Conner G.H.; Strauss M.; Abt A.B.; Velkley D.E., 1979: Tumor sterilization following high dose pre operative irradiation for advanced cancer of the larynx or pyriform sinus

Miller F.R., 1983: Tumor sub population interactions in metastasis

Delaini F.; Giavazzi R.; Vitti G.D.; Alessandri G.; Mantovani A.; Donati M.B., 1981: Tumor sublines with different metastatic capacity induce similar blood coagulation changes in the host

Itaya K.; Itoh M.; Tanaka I.; Ishii S I., 1981: Tumor suppressing effect of a monovalent monomeric derivative of concanavalin a obtained by photo alkylation with chloro acetamide

Sunkara P.S.; Prakash N.J.; Mayer G.D.; Sjoerdsma A., 1983: Tumor suppression with a combination of alpha di fluoromethyl ornithine and interferon

Rhodes J.; Bishop M.; Benfield J., 1979: Tumor surveillance how tumors may resist macrophage mediated host defense

Roberts L.K.; Schmitt M.; Daynes R.A., 1979: Tumor susceptibility generated in mice treated with sub carcinogenic doses of 8 methoxy psoralen and long wave uv light

Bernfeld P.; Homburger F., 1982: Tumor susceptibility in 2 mouse strains with varying doses of carcinogen

Henle K.J.; Monson T.P.; Nagle W.A.; Moss A.J., 1988: Tumor targeted cell killing with 8 hydroxyquinolylglucuronide

Udayachander, M.; Meenakshi, A.; Muthiah, R.; Sivanadham, M., 1987: Tumor targeting potential of liposomes encapsulating gallium 67 and antibody to dalton's lymphoma associated antigen anti dlaa

Behling H.; Schirmer A.; Krafft W.; Brueckmann D., 1988: Tumor therapy in patients with ovarian cancer at an advanced age

Sedlacek H.H.; Bengelsdorff K.H.; Hagmayer G.; Seiler F.R., 1987: Tumor therapy of neoplastic diseases with tumor cells and neuraminidase experimental studies on chessboard vaccination in transplantation tumors

Sedlacek H.H.; Hagmayer G.; Seiler F.R., 1986: Tumor therapy of neoplastic diseases with tumor cells and neuraminidase further experimental studies on chessboard vaccination in canine mammary tumors

Gatenby R.A.; Hammond N.D.; Brown D.Q., 1987: Tumor therapy with hematoporphyrin derivative and lasers via a percutaneous fiberoptic technique preclinical experiments

Roberts G.; Martyn A.L.; Dobson A.J.; Mccarthy W.H., 1981: Tumor thickness and histological type in malignant melanoma in new south wales australia 1970 1976

Nield D.V.; Saad M.N.; Khood C.T.K.; Lott M.; Ali M.H., 1988: Tumor thickness in malignant melanoma the limitations of frozen section

Radin D.R.; Ralls P.W.; Boswell W.D.Jr; Halls J.M., 1987: Tumor thrombosis of the inferior vena cava due to retroperitoneal germ cell tumor

Didier D.; Racle A.; Etievent J.P.; Weill F., 1987: Tumor thrombus of the inferior vena cava secondary to malignant abdominal neoplasms us and ct evaluation

Ahlborn T.N.; Gump F.E.; Bodian C.; Habif D.V.; Kister S., 1988: Tumor to fascia margin as a factor in local recurrence after modified radical mastectomy

Nielsen B.B., 1981: Tumor to tumor spread

Rockwell S.; Moulder J.E.; Martin D.F., 1984: Tumor to tumor variability in the hypoxic fractions of experimental rodent tumors

George G.; Cophignon J.; Rey A.; Laurian C., 1982: Tumor treatment with control of the vertebral artery in its transversary portion

Varani J.; Carey T.E.; Fligiel S.E.G.; Mckeever P.E.; Dixit V., 1987: Tumor type specific differences in cell substrate adhesion among human tumor cell lines

Williams L.E.; Duda R.B.; Proffitt R.T.; Beatty B.G.; Beatty J.D.; Wong J.Y.C.; Shively J.E.; Paxton R.J., 1988: Tumor uptake as a function of tumor mass a mathematic model

Webber M.M.; Verma R.; Chang B., 1986: Tumor uptake of 5 fluorouracil methotrexate and adriamycin vs gallium

Ogihara I.; Kojima S.; Jay M. , 1986: Tumor uptake of gallium 67 carrying liposomes

Anghileri L.J.; Crone M.C.; Thouvenot P.; Brunotte F.; Marchal C.; Robert J., 1984: Tumor uptake of high and low molecular weight fractions from gallium 67 citrate labeled blood plasma

Abrams, D. N.; Knaus, E. E.; Wiebe, L. I.; Helus, F.; Maier-Borst, W., 1981: Tumor uptake of radio labeled pyrimidine bases and pyrimidine nucleosides in animal models 4. iodine 123 labeled iodo 2' deoxy uridine

Lee, Y. W.; Mercer, J. R.; Wiebe, L. I.; Knaus, E. E., 1984: Tumor uptake of radiolabeled pyrimidine bases and pyrimidine nucleosides in animal models 6. 1 3' chlorine 36 labeled chloro 1 3' bromine 82 labeled bromo and 1 3' iodine 123 labeled iodo 3' deoxy beta d arabinofuranosyluracil

Lee, Y. W.; Giziewicz, J. B.; Knaus, E. E.; Wiebe, L. I., 1984: Tumor uptake of radiolabeled pyrimidine bases and pyrimidine nucleosides in animal models 7. carbon 14 labeled 5 ethyl 1 2' deoxy beta d ribofuranosyluracil

Lee, Y. W.; Iwashina, T.; Gati, W. P.; Knaus, E. E.; Wiebe, L. I., 1985: Tumor uptake of radiolabeled pyrimidine bases and pyrimidine nucleosides in animal models 8. synthesis and tissue distribution of tritiated n 2 hydroxyethoxymethyl 5 methyluracil

Abrams, D. N.; Lee, Y. W.; Mercer, J. R.; Knaus, E. E.; Wiebe, L. I., 1986: Tumor uptake of radiolabeled pyrimidine bases and pyrimidine nucleosides in animal models ix. radiolabeled 1 2' fluoro 2' deoxy beta d ribofuranosyluracil and 1 2' chloro 2' deoxy beta d ribofuranosyluracil

Tvete, S. T.; Hope, A.; Gadeholt, G.; Clausen, G., 1984: Tumor uptake of vincristine during close arterial vs. systemic constant rate infusion experiments on sarcoma transplants in the rat kidney

Ishiwata K.; Abe Y.; Matsuzawa T.; Ido T., 1988: Tumor uptake studies of d l 5 carbon 14 ornithine and d l 2 difluoromethyl 5 carbon 14 ornithine

Ishiwata K.; Ido T.; Abe Y.; Matsuzawa T.; Iwata R., 1988: Tumor uptake studies of s adenosyl l methyl carbon 11 methionine and l methyl carbon 11 methionine

Lynch H.T.; Ens J.; Lynch J.F.; Watson P., 1988: Tumor variation in three extended lynch syndrome ii kindreds

Eddy H.A., 1980: Tumor vascular responses following irradiation

Ramos I.M.; Taylor K.J.W.; Kier R.; Burns P.N.; Snower D.P.; Carter D., 1988: Tumor vascular signals in renal masses detection with doppler us

Kato T.; Tamakawa Y.; Murakami Y., 1984: Tumor vascularity under hypertension induced by intravenous infusion of angiotensin ii an angiographic observation

Walmsley J.G.; Granter S.R.; Hacker M.P.; Moore A.L.; Ershler W.B., 1987: Tumor vasculature in young and old hosts scanning electron microscopy of microcorrosion casts with microangiography light microscopy and transmission electron microscopy

Fujisawa I.; Minami S.; Tsutsui K.; Imura T.; Asano M.; Kitamura O.; Matsumoto M.; Ozawa K.; Torizuka K., 1986: Tumor vessels and contrast enhancement of hepatocellular carcinoma demonstrated by percutaneous transhepatic portography report of a case

Chen, S. S.; Spiegelman, I.; Cohen, C. J., 1976: Tumor virulence as a function of ultrastructural morphology and lymphatic invasion in patients with squamous cell carcinoma of the cervix uteri a preliminary study

Crowell R.L.; Friedman H.; Prier J.E., 1976: Tumor virus infections and immunity

Darcel, C. L., 1973: Tumor viruses of the fowl with special reference to avian leukosis including mareks disease

Zalcberg J.R.; Thompson C.H.; Lichtenstein M.; Leyden M.J.; Andrews J.T.; Sullivan J.R.; Mckenzie I.F.C., 1983: Tumor visualization using a radio labeled mono clonal antibody

Edeling, C. J., 1978: Tumor visualization using gallium 67 scintigraphy in children

Kayser K.; Toomes H.; Vollhaber H H.; Burkhardt H U., 1985: Tumor volume and macroscopic growth pattern of bronchogenic carcinoma

Atkinson E.N.; Brown B.W.; Montague E.D., 1986: Tumor volume nodal status and metastasis in breast cancer in women

Stephens, T. C.; Peacock, J. H., 1977: Tumor volume response initial cell kill and cellular re population in b 16 melanoma treated with cyclo phosphamide and 1 2 chloroethyl 3 cyclohexyl 1 nitroso urea

Epstein J.I.; Oesterling J.E.; Walsh P.C., 1988: Tumor volume versus percentage of specimen involved by tumor correlated with progression in stage a prostatic cancer

Aviles, D.; Jami, J.; Rousset, J. P.; Ritz, E., 1977: Tumor x host cell hybrids in the mouse chromosomes from the normal cell parent maintained in malignant hybrid tumors

Hoogenhout J.; Kazem I.; Jerusalem C.R.; Bakkeren J.A.J.; De Jong J.; Kal H.B.; Van Munster P.J.J., 1982: Tumor xeno transplantation in wistar rats after treatment with cyclo phosphamide and total lymphoid irradiation

Casey T.T.; Stone W.J.; Diraimondo C.R.; Brantley B.D.; Diraimondo C.V.; Gorevic P.D.; Page D.L., 1986: Tumoral amyloidosis of bone of beta 2 microglobulin origin in association with long term hemodialysis a new type of amyloid disease

Chiva P.; Pralea E.; Negulescu T.; Visan C., 1987: Tumoral anatomo clinic varieties of peritoneogenital echinococcosis

Billaud L.; Benabed K.; Requeda E.; Guilhaume B.; Louvel A.; Chapuis Y.; Bonnin A.; Luton J.P., 1987: Tumoral and pseudotumoral lesions of the adrenal gland area not to be misdiagnosed

Moreno-Koch, M. C.; Diaz-Yubero, M. A.; Tome-Paule, C.; Perez-Cuadrado, S., 1978: Tumoral antigenicity and anti neoplastic immunological state part 1 recurrence part 2 rejection of auto transplants

Maffei M.E.; Giussani M.L.; Patito J.A., 1986: Tumoral antigens and immune phenomena in malignancies of epithelial origin qualitative detection correlation and evaluation of findings

Roda J.E.; Heredero J.J.; Villarejo F.J.; Roda J.M., 1980: Tumoral antigens on experimental and human glio blastoma

Huang G K.; Liu Z Z.; Li D C.; Dong C K., 1982: Tumoral calcinosis

Hacihanefioglu, U., 1978: Tumoral calcinosis a clinical and pathological study of 11 unreported cases in turkey

Mckee P.H.; Liomba N.G.; Hutt M.S.R., 1982: Tumoral calcinosis a pathological study of 56 cases

Kindblom L G.; Gunterberg B., 1988: Tumoral calcinosis an ultrastructural analysis and consideration of pathogenesis

Kishimoto S.; Nagatani H.; Miyashita A.; Kobayashi K., 1984: Tumoral calcinosis arisen from the intramuscular injection of gold

Wolpe F.M.; Khedkar N.Y.; Gordon D.; Werner P.; Shirazi P.; Al Sabban M.H., 1987: Tumoral calcinosis associated with sarcoidosis and positive bone and gallium imaging

Davies M.; Clements M.R.; Mawer E.B.; Freemont A.J., 1987: Tumoral calcinosis clinical and metabolic response to phosphorus deprivation

Clarke E.; Swischuk L.E.; Hayden C.K.Jr, 1984: Tumoral calcinosis diaphysitis and hyper phosphatemia

Zerwekh J.E.; Sanders L.A.; Townsend J.; Pak C.Y.C., 1980: Tumoral calcinosis evidence for concurrent defects in renal tubular phosphorus transport and in 1 alpha 25 di hydroxy cholecalciferol synthesis

Suzuki K.; Takahashi S.; Ito K.; Tanaka Y.; Sezai Y., 1979: Tumoral calcinosis in a patient undergoing hemo dialysis

Bostrom B., 1981: Tumoral calcinosis in an infant

Dryll A.; Bardin T.; Lansaman J.; Van P.T.; Bard H.; Ryckewaert A.; Cywiner Golenzer C., 1984: Tumoral calcinosis light microscopic and electron microscopic study with electron diffraction and x ray microanalysis of the mineral deposit

St Clair J.T.; Majmudar B., 1980: Tumoral calcinosis masquerading as metastatic carcinoma

Leicht E.; Tkocz H J.; Seeliger H.; Lauffenburger T.; Haas H.G., 1980: Tumoral calcinosis observations during 6 years

Espinosa Hernandez A.; Fernandez Capel A.; Gomez Yelo A.; Leal Adan R.; Reus Pintado M., 1981: Tumoral calcinosis presentation of 2 cases

Croock A.D.; Silver R.M., 1987: Tumoral calcinosis presenting as adhesive capsulitis case report and literature review

Metzker A.; Eisenstein B.; Oren J.; Samuel R., 1988: Tumoral calcinosis revisited common and uncommon features report of ten cases and review

Balachandran S.; Abbud Y.; Prince M.J.; Chausmer A.B., 1980: Tumoral calcinosis scintigraphic studies of an affected family

Perez-Cuadrado, S.; Moreno-Koch, M. C.; Tome-Paule, C., 1978: Tumoral cross antigenicity between the experimental neoplasms cam cah caoy and cam 4

Morais De Sa C.A.; Gomes M.D.; Miguez L.A.; Rebelo P.A.D.; Pacheco R.G.; Klein B.; Houli J. , 1981: Tumoral dermato poly myositis

Rudnitskaya E.I.; Moskalev Yu I.; Semenov A.I., 1982: Tumoral effect of small doses of curium 244

Bambirra E.A.; Margarida A.; Nogueira M.F.; Andrade I.E.D., 1985: Tumoral form of ascariasis report of a case

Taptas, J. N.; Kordiolis, N.; Charalambopoulos, F., 1978: Tumoral forms of bournevilles tuberous sclerosis syndrome the clinical symptomatic and therapeutic importance of concomitant hydrocephalus

Santamaria Sandi J.; Elorza Olabegoya R.; Beitia Martin J.J.; Vazquez Garcia J.A., 1985: Tumoral hypophosphatemic osteomalacia

Veress, B.; Malik, M. O. A.; El-Hassen, A. M., 1976: Tumoral lipo calcinosis a clinico pathological study of 20 cases

Lopez A., 1979: Tumoral pathology in spiders

Zucali R.; Kenda R., 1985: Tumorectomy plus radiotherapy in the management of breast cancer

Ferguson D.J.; Urban J.L., 1980: Tumori lysin collected in diffusion chambers and restraint of foreign body tumorigenesis

Monsigny M.; Roche A C.; Bailly P., 1984: Tumoricidal activation of murine alveolar macrophages by muramyl di peptide substituted mannosylated serum albumin

Buessow S.C.; Gillespie G.Y.; Mahaley M.S., 1984: Tumoricidal activity of an acute promyelocytic leukemia cell line hl 60 is augmented by human interferon alpha

Kleinerman E.S.; Schroit A.J.; Fogler W.E.; Fidler I.J., 1983: Tumoricidal activity of human monocytes activated in vitro by free and liposome encapsulated human lymphokines

Cheung H.T.; Cantarow W.D.; Sundharadas G., 1979: Tumoricidal activity of macrophages induced by lipo poly saccharide and its inhibition by a low molecular weight factor extracted from tumors

Peri G.; Polentarutti N.; Sessa C.; Mangioni C.; Mantovani A., 1981: Tumoricidal activity of macrophages isolated from human ascitic and solid ovarian carcinomas augmentation by interferon lymphokines and endo toxin

Gavioli R.; Spisani S.; Giuliani A.L.; Traniello S., 1987: Tumoricidal activity of neutrophils

Masuda S.; Seki K.; Nishihara S., 1984: Tumoricidal adsorption of staphylococcus aureus organisms on ehrlich ascites tumor cells sensitized with rabbit antibody

Martin F.; Caignard A.; Olsson O.; Jeannin J.F.; Leclerc A., 1982: Tumoricidal effect of macrophages exposed to adriamycin in vivo or in vitro

Klostergaard, J.; Foster, W. A.; Leroux, M. E., 1987: Tumoricidal effector mechanisms of murine bcg activated macrophages i. parameters of production and initial characterization of a cytolytic factor serologically related to necrosin

Klostergaard J.; Leroux M.E.; Ezell S.M.; Kull F.C.Jr, 1987: Tumoricidal effector mechanisms of murine bcg activated macrophages mediation of cytolysis mitochondrial respiration inhibition and release of intracellular iron by distinct mechanisms

Heggers J.P.; Robson M.C.; Yetter J.F.; Kreig R.E.Jr; Jennings P.B., 1979: Tumoricidal effects of mycobacterium ulcerans toxin on murine adeno carcinoma c 3hba

Kolodny G.M.; Rose C., 1983: Tumoricidal effects of sodium hexa chloro iridate on an ascitic tumor in mice

Fidler, I. J.; Darnell, J. H.; Budmen, M. B., 1976: Tumoricidal properties of mouse macrophages activated with mediators from rat lymphocytes stimulated with concanavalin a

Balint J.Jr; Ikeda Y.; Langone J.J.; Shearer W.T.; Daskal I.; Meek K.; Cook G.; Henry J.; Terman D.S., 1984: Tumoricidal response following perfusion over immobilized protein a identification of immuno globulin oligomers in serum after perfusion and their partial characterization

Meltzer, M. S., 1976: Tumoricidal responses in vitro of peritoneal macrophages from conventionally housed and germ free nude mice

Henriet M.; Schtickzelle J C.; Deviere J., 1984: Tumoriform muscular infarction in the diabetic anatomoclinical study of 1 case and review

Mitchel R.E.J.; Morrison D.P.; Gragtmans N.J., 1987: Tumorigenesis and carcinogenesis in mouse skin treated with hyperthermia during stage i or stage ii of tumor promotion

Yamamoto H., 1985: Tumorigenesis and cystic lesion of the liver by n bis 2 hydroxypropylnitrosamine in ddy mice

Allen J.W.; Stoner G.D.; Pereira M.A.; Backer L.C.; Sharief Y.; Hatch G.G.; Campbell J.A.; Stead A.G.; Nesnow S., 1986: Tumorigenesis and genotoxicity of ethylcarbamate and vinylcarbamate in rodent cells

Konstantinidis A.; Smulow J.B.; Sonnenschein C., 1982: Tumorigenesis at a predetermined oral site after 1 intra peritoneal injection of n nitroso n methyl urea

Coffin D.L.; Palekar L.D.; Cook P.M., 1982: Tumorigenesis by a ferro actinolite mineral

Toth B., 1980: Tumorigenesis by benzo a pyrene administered intra colonically

Peters G.; Brookes S.; Smith R.; Dickson C., 1983: Tumorigenesis by mouse mammary tumor virus evidence for a common region for pro virus integration in mammary tumors

Dickson C.; Smith R.; Brookes S.; Peters G., 1984: Tumorigenesis by mouse mammary tumor virus pro viral activation of a cellular gene in the common integration region int 2

Toth B.; Nagel D.; Patil K., 1980: Tumorigenesis by n n propyl n formyl hydrazine in mice

Anderson L.M.; Rice J.M., 1987: Tumorigenesis in athymic nude mouse skin by chemical carcinogens and uv light

Pinkert C.A.; Brinster R.L.; Palmiter R.D.; Wong C.; Butel J.S., 1987: Tumorigenesis in transgenic mice by a nuclear transport defective sv 40 large t antigen gene

Chapekar T.N., 1982: Tumorigenesis of autologous intra splenic ovarian transplants in swiss mice

Sinha D.K.; Pazik J.E., 1981: Tumorigenesis of mammary gland by 7 12 di methyl benz a anthracene during pregnancy relationship with dna synthesis

Pearson R.D., 1981: Tumorigenesis the subterfuge of selection

Toth B.; Nagel D.; Raha C., 1981: Tumorigenesis with 1 1 di allyl hydrazine in mice

Toth B.; Nagel D.; Patil K., 1980: Tumorigenic action of n n butyl n formyl hydrazine in mice

Kazumi, T.; Yoshino, G.; Fujii, S.; Baba, S., 1978: Tumorigenic action of streptozotocin on the pancreas and kidney in male wistar rats

Levin W.; Buening M.K.; Wood A.W.; Chang R.L.; Thakker D.R.; Jerina D.M.; Conney A.H., 1979: Tumorigenic activity of 3 methyl cholanthrene metabolites on mouse skin and in new born mice

Buening M.K.; Levin W.; Wood A.W.; Chang R.L.; Lehr R.E.; Taylor C.W.; Yagi H.; Jerina D.M.; Conney A.H., 1980: Tumorigenic activity of benzo e pyrene derivatives on mouse skin and in new born mice

Gelinas C.; Bouchard L.; Bastin M., 1981: Tumorigenic activity of cloned polyoma virus dna in new born rats

Lavoie E.J.; Braley J.; Rice J.E.; Rivenson A., 1987: Tumorigenic activity of non alternant polynuclear aromatic hydrocarbons in newborn mice

Bouchard L.; Gelinas C.; Asselin C.; Bastin M., 1984: Tumorigenic activity of polyoma virus and sv 40 dna species in new born rodents

Lavoie, E. J.; Prokopczyk, G.; Rigotty, J.; Czech, A.; Rivenson, A.; Adams, J. D., 1987: Tumorigenic activity of the tobacco specific nitrosamines 4 methylnitrosamino 1 3 pyridyl 1 butanone nnk 4 methylnitrosamino 4 3 pyridyl 1 butanol iso nnal and n' nitrosonornicotine nnn on topical application to sencar mice

Schmeltz, I.; Abidi, S.; Hoffmann, D., 1977: Tumorigenic agents in unburned processed tobacco n nitroso di ethanolamine and 1 1 di methyl hydrazine

Greig R.G.; Koestler T.P.; Trainer D.L.; Corwin S.P.; Miles L.; Kline T.; Sweet R.; Yokoyama S.; Poste G., 1985: Tumorigenic and metastatic properties of normal and ras transfected nih 3t3 cells

Heywood R.; Wood J.D.; Majeed S.K., 1985: Tumorigenic and toxic effect of o s dibenzoylthiamin hydrochloride in prolonged dietary administration to rats

Serano R.D.; Pegram C.N.; Bigner D.D., 1980: Tumorigenic cell culture lines from a spontaneous vm dk murine astro cytoma

Tripier M.F.; Hassoun J.; De Micco C.; Meyer G.; Toga M., 1979: Tumorigenic clones of hamster brain cells transformed in vitro by polyoma virus ultrastructural and immuno histochemical study

Land H.; Parada L.F.; Weinberg R.A., 1983: Tumorigenic conversion of primary embryo fibroblasts requires at least 2 cooperating oncogenes

Toth, B., 1978: Tumorigenic effect of 1 hydrazino phthalazine hydro chloride in mice

Tsuda, H.; Hananouchi, M.; Tatematsu, M.; Hirose, M.; Hirao, K.; Takahashi, M.; Ito, N., 1976: Tumorigenic effect of 3 amino 1 h 1 2 4 triazole on rat thyroid

Toth, B.; Tompa, A.; Patil, K., 1977: Tumorigenic effect of 4 methyl phenyl hydrazine hydro chloride in swiss mice

Furst, A., 1978: Tumorigenic effect of an organo manganese compound on f 344 rats and swiss albino mice

Shivapurkar N.M.; Ranadive S.N.; Gothoskar S.V.; Bhide S.V.; Ranadive K.J., 1980: Tumorigenic effect of aqueous and poly phenolic fractions of betel nut in swiss strain mice

Zackheim H.S.; Smuckler E.A., 1980: Tumorigenic effect of topical mechlorethamine carmustine and lomustine in mice

Toth, B.; Shimizu, H., 1976: Tumorigenic effects of chronic administration of benzyl hydrazine di hydro chloride and phenyl hydrazine hydro chloride in swiss mice

Pollard M.; Luckert P.H., 1985: Tumorigenic effects of direct acting and indirect acting chemical carcinogens in rats on a restricted diet

Anderson E.C.; Holland L.M.; Prine J.R.; Smith D.M., 1979: Tumorigenic hazard of particulate alpha activity in syrian hamster lungs

Pettijohn D.E.; Pfenninger O.; Brown J.; Duke R.; Olsson L., 1988: Tumorigenic human squamous lung cancer cells have defined cell surface carbohydrates that are absent from nontumorigenic cells

Rheinwald J.G.; Beckett M.A., 1981: Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultured from human squamous cell carcinomas

Jacubovich R.; Cabrillat H.; Gerlier D.; Bailly M.; Dore J.F., 1985: Tumorigenic phenotypes of human melanoma cell lines in nude mice determined by an active antitumor mechanism

Leavitt J., 1983: Tumorigenic potential of human fibroblasts as a function of ability to express a novel form of influenza a nucleo capsid protein

Upton C.; Mcfadden G., 1986: Tumorigenic poxviruses analysis of viral dna sequences implicated in the tumorigenicity of shope fibroma virus and malignant rabbit virus

Delange A.M.; Macaulay C.; Block W.; Mueller T.; Mcfadden G., 1984: Tumorigenic poxviruses construction of the composite physical map of the shope fibroma virus genome

Upton C.; Macen J.L.; Maranchuk R.A.; Delange A.M.; Mcfadden G., 1988: Tumorigenic poxviruses fine analysis of the recombination junctions in malignant rabbit fibroma virus a recombinant between shope fibroma virus and myxoma virus

Upton C.; Delange A.M.; Mcfadden G., 1987: Tumorigenic poxviruses genomic organization and dna sequence of the telomeric region of the shope fibroma virus genome

Block W.; Upton C.; Mcfadden G., 1985: Tumorigenic poxviruses genomic organization of malignant rabbit virus a recombinant between shope fibroma virus and myxoma virus

Macaulay C.; Upton C.; Mcfadden G., 1987: Tumorigenic poxviruses transcriptional mapping of the terminal inverted repeats of shope fibroma virus

Wolff G.L.; Roberts D.W.; Morrissey R.L.; Greenman D.L.; Allen R.R.; Campbell W.L.; Bergman H.; Nesnow S.; Frith C.H., 1987: Tumorigenic responses to lindane in mice potentiation by a dominant mutation

Jariwalla R.J.; Aurelian L.; Ts'o P.O.P., 1980: Tumorigenic transformation induced by a specific fragment of dna from herpes simplex virus type 2

Wallace J.S.; Fleming K.A.; Tarin D., 1988: Tumorigenic transformation of mouse nih 3t3 cells by transfection with plasmid psv 2neo

Picard J.J.; Pelle R.; Schonne E.; Dworkin Rastl E.; Dworkin M.B., 1986: Tumorigenic xenopus cells express several maternal and early embryonic messenger rna species

Paraskeva C.; Gallimore P.H., 1980: Tumorigenicity and in vitro characteristics of rat liver epithelial cells and their adenovirus transformed derivatives

Giacomoni D., 1979: Tumorigenicity and intra cisternal a particle expression of hybrids between murine myeloma and lymphocytes

Howell, A. N.; Sager, R., 1978: Tumorigenicity and its suppression in cybrids of mouse and chinese hamster cell lines

Karjalainen H.E.; Salmi A.; Mantyjarvi R.A., 1979: Tumorigenicity and karyotype of rat embryo cell lines transformed by bk virus

Collins J.L.; Patek P.Q.; Cohn M., 1981: Tumorigenicity and lysis by natural killers

El Bayoumy K.; Hecht S.S.; Sackl T.; Stoner G.D., 1984: Tumorigenicity and metabolism of 1 nitropyrene in a j mice

Price J.E.; Sauder D.N.; Fidler I.J., 1988: Tumorigenicity and metastatic behavior in nude mice of two human squamous cell carcinoma lines that differ in production of the cytokine etaf il 1

Toth B.; Rogan E.; Walker B., 1984: Tumorigenicity and mutagenicity studies with capsaicin of hot peppers

Pasquale S.R.; Jones G.R.; Doersen C J.; Weissman B.E., 1988: Tumorigenicity and oncogene expression in pediatric cancers

Robinson K.M.; Maistry L., 1983: Tumorigenicity and other properties of cells from 10 continuous human esophageal carcinoma cell lines in nude mice

Grady, L. J.; North, A. B., 1976: Tumorigenicity and the quantity of virus dna in polyoma transformed and revertant cell lines

Huber B.E.; Dearfield K.L.; Williams J.R.; Heilman C.A.; Thorgeirsson S.S., 1985: Tumorigenicity and transcriptional modulation of c myc and n ras oncogenes in a human hepatoma cell line

Foa C.; Berebbi M.; Lipcey C.; Galindo J.R.; Bonneau H., 1982: Tumorigenicity and tumor graft rejection of polyoma virus transformed fibroblast t lymphocyte hybrids

Mantel N.; Tukey J.W.; Ciminera J.L.; Heyse J.F., 1982: Tumorigenicity assays including use of the jackknife

Weikel J.H.Jr; Kelly W.A., 1979: Tumorigenicity assays of sotalol hydro chloride in rats and mice

Alhonen-Hongisto, L.; Kallio, A.; Sinervirta, R.; Janne, O. A.; Gahmberg, C. G.; Janne, J., 1985: Tumorigenicity cell surface glycoprotein changes and ornithine decarboxylase ec gene pattern in ehrlich ascites carcinoma cells

Silagi, S.; Beju, D.; Wrathall, J.; Deharven, E., 1972: Tumorigenicity immunogenicity and virus production in mouse melanoma cells treated with 5 bromodeoxy uridine

Klug T.L.; Salzman S.; Quinn A.; Melincoff G.A.; Sedmak D.D.; Tubbs R.R.; Zurawski V.R.Jr, 1984: Tumorigenicity in athymic mice of the human colon carcinoma cell line sw 1116 expressing the tumor associated antigenic determinant ca 19 9

Shouval D.; Reid L.M.; Chakraborty P.R.; Ruiz Opazo N.; Morecki R.; Gerber M.; Thung S.N.; Shafritz D.A., 1981: Tumorigenicity in nude mice of a human hepatoma cell line containing hepatitis b virus dna

Bosze Z.; Venetianer A., 1985: Tumorigenicity in nude mice of dexamethasone sensitive and dexamethasone resistant differentiated and dedifferentiated hepatoma cells

U.H.S.; Kelley P.; Ashbaugh S.; Tatsukawa K.; Werner R., 1987: Tumorigenicity in the nude mouse of cocultures derived from two nontumorigenic cell types human pituitary adenomas and mouse c3h 10t1 2 fibroblasts

Marquardt, H.; Philips, F. S.; Sternberg, S. S., 1976: Tumorigenicity in vivo and induction of malignant transformation and mutagenesis in cell cultures by adriamycin and daunomycin

Westendorf J.; Marquardt H.; Ketkar M.B.; Mohr U.; Marquardt H., 1983: Tumorigenicity in vivo and induction of mutagenesis and dna repair in vitro by aclacinomycin a and marcellomycin structure activity relationship and predictive value of short term tests

Higashida H.; Kano Tanaka K.; Tanaka T.; Fukami H.; Natsume Sakai S., 1985: Tumorigenicity major histocompatibility antigens and karyotypes of interspecific hybrids between mouse neuroblastoma and rat glioma or liver cells

Mori, Y.; Nagai, H.; Hori, T.; Niwa, T.; Toyoshi, K.; Koda, A.; Kawada, K.; Ojima, A., 1981: Tumorigenicity of 3' hydroxymethyl 3' formyl and 3' carboxy derivatives of 4 di methylamino azo benzene in rat liver

Wood, A. W.; Levin, W.; Chang, R. L.; Lehr, R. E.; Schaefer-Ridder, M.; Karle, J. M.; Jerina, D. M.; Conney, A. H., 1977: Tumorigenicity of 5 di hydro diols of benz a anthracene on mouse skin exceptional activity of benz a anthracene 3 4 di hydro diol

Hecht S.S.; Radok L.; Amin S.; Huie K.; Melikian A.A.; Hoffmann D.; Pataki J.; Harvey R.G., 1985: Tumorigenicity of 5 methylchrysene dihydrodiols and dihydrodiol epoxides in newborn mice and on mouse skin

Cavalieri E.; Rogan E.; Cremonesi P.; Higginbotham S.; Salmasi S., 1988: Tumorigenicity of 6 halogenated derivatives of benzo a pyrene in mouse skin and rat mammary gland

Wislocki P.G.; Juliana M.M.; Macdonald J.S.; Chou M.W.; Yang S.K.; Lu A.Y.H., 1981: Tumorigenicity of 7 12 di methyl benz a anthracene its hydroxymethylated derivatives and selected di hydro diols in the new born mouse

Meager, A.; Nairn, R.; Hughes, R. C.; Garrett, A. J.; Reeson, D. E., 1978: Tumorigenicity of adenovirus 5 transformed bhk cell lines with various transformation associated properties

Bober F.J.; Birk D.; Shenk T.; Raska K.Jr, 1988: Tumorigenicity of adenovirus transformed cells collagen interaction and cell surface laminin are controlled by the serotype origin of the e1a and e1b genes

Sawada Y.; Fohring B.; Shenk T.E.; Raska K.Jr, 1985: Tumorigenicity of adenovirus transformed cells region e 1a of adenovirus 12 confers resistance to natural killer cells

Ishinishi N.; Yamamoto A.; Hisanaga A.; Inamasu T., 1983: Tumorigenicity of arsenic tri oxide to the lung in syrian golden hamsters by intermittent instillations

Chang R.L.; Levin W.; Wood A.W.; Lehr R.E.; Kumar S.; Yagi H.; Jerina D.M.; Conney A.H., 1981: Tumorigenicity of bay region diol epoxides and other benzo ring derivatives of di benzo a h pyrene and di benzo a i pyrene on mouse skin and in new born mice

Buening M.K.; Levin W.; Karle J.M.; Yagi H.; Jerina D.M.; Conney A.H., 1979: Tumorigenicity of bay region epoxides and other derivatives of chrysene and phenanthrene in new born mice

Wislocki, P. G.; Kapitulnik, J.; Levin, W.; Conney, A. H.; Yagi, H.; Jerina, D. M., 1978: Tumorigenicity of benzo a pyrene 4 5 7 8 9 10 and 11 12 oxides in new born mice

Pilkington G.J.; Darling J.L.; Lantos P.L.; Thomas D.G.T., 1985: Tumorigenicity of cell lines vmdk derived from a spontaneous murine astrocytoma histology fine structure and immunocytochemistry of tumors

Roos D.S.; Choppin P.W., 1984: Tumorigenicity of cell lines with altered lipid composition

Jones C.L.; Spindler K.R.; Holland J.J., 1980: Tumorigenicity of cells persistently infected with vesicular stomatitis virus in nude mice

Bernards R.; Schrier P.I.; Houweling A.; Bos J.L.; Van Der Eb A.J.; Zijlstra M.; Melief C.J.M., 1983: Tumorigenicity of cells transformed by adenovirus type 12 by evasion of t cell immunity

Gee C.J.; Harris H., 1979: Tumorigenicity of cells transformed by sv 40 and of hybrids between such cells and normal di ploid cells

O'donnell R.W.; Noguchi P.D.; Petricciani J.C., 1981: Tumorigenicity of chromosomally abnormal human cultured cells in 2 xenogenic organ culture assays

Arai M.; Hibino T., 1983: Tumorigenicity of citrinin in male f 344 rats

Chang R.L.; Levin W.; Wood A.W.; Kumar S.; Yagi H.; Jerina D.M.; Lehr R.E.; Conney A.H., 1984: Tumorigenicity of dihydrodiols and diol epoxides of benz c acridine in newborn mice

Pierce G.B.; Lewis S.H.; Miller G.J.; Moritz E.; Miller P., 1979: Tumorigenicity of embryonal carcinoma as an assay to study control of malignancy by the murine blastocyst

Chang R.L.; Levin W.; Wood A.W.; Yagi H.; Tada M.; Vyas K.P.; Jerina D.M.; Conney A.H., 1983: Tumorigenicity of enantiomers of chrysene 1 2 di hydro diol and of the dia stereomeric bay region chrysene 1 2 diol 3 4 epoxides on mouse skin and in new born mice

Kelekar A.; Cole M.D., 1986: Tumorigenicity of fibroblast lines expressing the adenovirus e 1a cellular p 53 or normal c myc genes

Busby W.F.Jr; Goldman M.E.; Newberne P.M.; Wogan G.N., 1984: Tumorigenicity of fluoranthene in newborn mouse lung adenoma bioassay

Axelrod D.E.; Majumdar S.K.; Wivell J.A.; Terry R.W., 1980: Tumorigenicity of friend murine erythro leukemia cell lines differing in spontaneous differentiation rates

Haddada H.; Lewis A.M.Jr; Sogn J.A.; Coligan J.E.; Cook J.L.; Walker T.A.; Levine A.S., 1986: Tumorigenicity of hamster and mouse cells transformed by adenovirus types 2 and 5 is not influenced by the level of class i major histocompatibility antigens expressed on the cells

Shortland J.R.; Mousawy K.M.; Rees R.C.; Potter C.W., 1979: Tumorigenicity of herpesvirus hominis type 2 transformed cells line 333 8 9 in adult hamsters

Adelman S.F.; Howett M.K.; Rapp F., 1981: Tumorigenicity of herpesvirus transformed cells correlates with production of plasminogen activator

Watanabe S.; Kotake S.; Nozawa A.; Muto T.; Uchida S., 1982: Tumorigenicity of human bk papovavirus plaque isolates wild type and plaque morphology mutant in hamsters

Nilsson, K.; Giovanella, B. C.; Stehlin, J. S.; Klein, G., 1977: Tumorigenicity of human hematopoietic cell lines in athymic nude mice

Benedict W.F.; Weissman B.E.; Mark C.; Stanbridge E.J., 1984: Tumorigenicity of human ht 1080 fibrosarcoma x normal fibroblast hybrids chromosome dosage dependency

Morten J.E.N.; Hay J.H.; Steel C.M.; Foster M.E.; De Angelis C.L.; Busuttil A., 1984: Tumorigenicity of human lymphoblastoid cell lines acquired during in vitro culture and associated with chromosome gains

Ohsugi Y.; Gershwin M.E.; Owens R.B.; Nelson Rees W.A., 1980: Tumorigenicity of human malignant lympho blasts comparative study with unmanipulated nude mice anti lymphocyte serum treated nude mice and x irradiated nude mice

Aubert, C.; Rouge, F.; Galindo, J. R., 1980: Tumorigenicity of human malignant melanocytes in nude mice in relation to their differentiation in vitro

Hatanaka M.; Klein R., 1979: Tumorigenicity of indian muntjac di ploid cells by the pro viral integration of sarcoma gene of a mouse retrovirus

Yamamoto A.; Hisanaga A.; Ishinishi N., 1987: Tumorigenicity of inorganic arsenic compounds following intratracheal instillations to the lungs of hamsters

Saito M.; Isaka H.; Tosu M.; Sekicuchi T., 1985: Tumorigenicity of interspecific cybrid cells formed between mouse teratocarcinoma cells and rat myoblast cytoplasts or human melanoma cell cytoplasts

Aden, D. P.; Knowles, B. B., 1977: Tumorigenicity of intraspecific somatic cell hybrids in nude mice

Toth B.; Patil K., 1982: Tumorigenicity of minute dose levels on n methyl n formyl hydrazine of gyromitra esculenta

Tough D.F.; Chow D.A., 1988: Tumorigenicity of murine lymphomas selected through fluorescence detected natural antibody binding

Iversen O.H., 1980: Tumorigenicity of n nitroso di ethylamine n nitroso methylamine and n nitroso di phenylamine in skin painting experiments a study utilizing the tetrazolium test and skin applications on hairless mice

Takimoto T.; Ogura H.; Ohno S.; Umeda R.; Hatano M., 1984: Tumorigenicity of nasopharyngeal carcinoma hybrid cell line

Heumann, R.; Stavrou, D.; Reiser, G.; Ocalan, M.; Hamprecht, B., 1977: Tumorigenicity of neuro blastoma x glioma hybrid cells in nude mice and re introduction of transplanted cells into culture

Wislock P.G.; Bagan E.S.; Lu A.Y.H.; Dooley K.L.; Fu P.P.; Han Hsu H.; Beland F.A.; Kadlubar F.F., 1986: Tumorigenicity of nitrated derivatives of pyrene benz a anthracene chrysene and benzo a pyrene in the newborn mouse assay

Levin W.; Chang R.L.; Wood A.W.; Thakker D.R.; Yagi H.; Jerina D.M.; Conney A.H., 1986: Tumorigenicity of optical isomers of the diastereomeric bay region 3 4 diol 1 2 epoxides of benzo c phenanthrene in murine tumor models

Kahn P.; Nakamura K.; Shin S.; Smith R.E.; Weber M.J., 1982: Tumorigenicity of partial transformation mutants of rous sarcoma virus

Vandepol S.B.; Holland J.J., 1986: Tumorigenicity of persistent infected tumors in nude mice is a function of both virus and host cell type

Steinberg B.M.; Rifkin D.; Shin S I.; Boone C.; Pollack R., 1979: Tumorigenicity of revertants from an sv 40 transformed line

Vasiliev J.M.; Moizhess T.G., 1982: Tumorigenicity of sarcoma cells is enhanced by the local environment of implanted foreign body

Koppel H.; Pilkington G.J.; Lantos P.L., 1988: Tumorigenicity of six clones of a cultured neoplastic cell line derived from a spontaneous murine astrocytoma morphology and immunocytochemistry of tumors

Woodworth C.D.; Kreider J.W.; Mengel L.; Miller T.; Meng Y.; Isom H.C., 1988: Tumorigenicity of sv 40 hepatocyte cell lines effect of in vitro and in vivo passage on expression of liver specific genes and oncogenes

Kahn P.; Topp W.C.; Shin S I., 1983: Tumorigenicity of sv 40 transformed human and monkey cells in immuno deficient mice

Koprowski, H.; Croce, C. M., 1977: Tumorigenicity of sv 40 transformed human cells and mouse human hybrids in nude mice

Isom H.C.; Tevethia M.J.; Kreider J.W., 1981: Tumorigenicity of sv 40 transformed rat hepatocytes

Hays E.F.; Weinroth S.E.; Macleod C.L.; Kitada S., 1986: Tumorigenicity of t lymphoma t lymphoma hybrids and t lymphoma normal cell hybrids

Flatow U.; Rabson A.B.; Rabson A.S. , 1987: Tumorigenicity of t24 urinary bladder carcinoma cell sublines

Hough M.R.; White B.N.; Holden J.J.A., 1988: Tumorigenicity of ten karyotypically distinct cell types present in the human melanoma cell line mewo a

Toth, B.; Nagel, D.; Erickson, J.; Kupper, R., 1976: Tumorigenicity of tetra methyl hydrazine hydro chloride in swiss mice

Tateyama I.; Tominaga T.; Kamitani N.; Mori T., 1984: Tumorigenicity of the cell lines ttk 1 cell lines derived from normal human decidua in nude mice

Stadel J.M.; Johnson R.K.; Mirabelli C.K.; Powers D.A.; Sung C M.; Faucette L.F.; Mccabe F.L.; Crooke S.T., 1988: Tumorigenicity of the cyc negative variant of the s49 murine lymphoma deficient in the g s alpha subunit of adenylate cyclase

Buening M.K.; Levin W.; Wood A.W.; Chang R.L.; Yagi H.; Karle J.M.; Jerina D.M.; Conney A.H., 1979: Tumorigenicity of the di hydro diols of di benz a h anthracene on mouse skin and in new born mice

Chang R.L.; Levin W.; Wood A.W.; Lehr R.E.; Kumar S.; Yagi H.; Jerina D.M.; Conney A.H., 1981: Tumorigenicity of the dia stereomeric bay region benzo e pyrene 9 10 diol 11 12 epoxides in new born mice

Wislocki P.G.; Buening M.K.; Levin W.; Lehr R.E.; Thakker D.R.; Jerina D.M.; Conney A.H., 1979: Tumorigenicity of the dia stereomeric benz a anthracene 3 4 diol 1 2 epoxides and the dextro enantiomers and levo enantiomers of benz a anthracene 3 4 di hydrodiol in new born mice

Reddy J.K.; Qureshi S.A., 1979: Tumorigenicity of the hypo lipidemic peroxisome proliferator ethyl alpha p chlorophenoxy iso butyrate clofibrate in rats

Buening, M. K.; Wislocki, P. G.; Levin, W.; Yagi, H.; Thakker, D. R.; Akagi, H.; Koreeda, M.; Jerina, D. M.; Conney, A. H., 1978: Tumorigenicity of the optical enantiomers of the dia stereomeric benzo a pyrene 7 8 diol 9 10 epoxides in new born mice exceptional activity of dextro 7 beta 8 alpha di hydroxy 9 alpha 10 alpha epoxy 7 8 9 10 tetra hydro benzo a pyrene

Urban, H.; Danz, M., 1976: Tumorigenicity of tri nitroso tri methylenetriamine dissolved in di methyl sulfoxide

Lehman J.M.; Estes P., 1982: Tumorigenicity of tsa and wild type sv 40 transformed cells inoculated onto the chicken chorio allantoic membrane

Levenbook I.S.; Petricciani J.C.; Elisberg B.L., 1984: Tumorigenicity of vero cells

Shin, S. I.; Freedman, V. H.; Risser, R.; Pollack, R., 1975: Tumorigenicity of virus transformed cells in nude mice is correlated specifically with anchorage independent growth in vitro

Kapitulnik, J.; Wislocki, P. G.; Levin, W.; Yagi, H.; Jerina, D. M.; Conney, A. H., 1978: Tumorigenicity studies with diol epoxides of benzo a pyrene which indicate that racemic trans 7 beta 8 alpha di hydroxy 9 alpha 10 alpha epoxy 7 8 9 10 tetra hydro benzo a pyrene is an ultimate carcinogen in new born mice

Ernst H.; Ohshima H.; Bartsch H.; Mohr U.; Reichart P., 1987: Tumorigenicity study in syrian hamsters fed areca nut together with nitrite

Inai K.; Aoki Y.; Akamizu H.; Eto R.; Nishida T.; Tokuoka S., 1985: Tumorigenicity study of butyl p hydroxybenzoate and isobutyl p hydroxybenzoate administered orally to mice

Kobuke T.; Inai K.; Nambu S.; Ohe K.; Takemoto T.; Matsuki K.; Nishina H.; Huang I B.; Tokuoka S., 1985: Tumorigenicity study of disodium glycyrrhizinate administered orally to mice

Otofuji T.; Horikawa K.; Maeda T.; Sano N.; Izumi K.; Otsuka H.; Tokiwa H., 1987: Tumorigenicity test of 1 3 and 1 8 dinitropyrene in balb c mice

Ito A.; Naito M.; Naito Y.; Watanabe H., 1983: Tumorigenicity test of n nitro 2 furfurylidene 1 amino hydantoin by dietary administration in bdf 1 mice

Levenbook I.S.; Petricciani J.C.; Qi Y.; Elisberg B.L.; Rogers J.L.; Jackson L.B.; Wierenga D.E.; Webster B.A., 1985: Tumorigenicity testing of primate cell lines in nude mice muscle organ culture and for colony formation in soft agarose

Li, J.; Mansfield, J. M.; Wallace, J. H., 1977: Tumoristatic effects of nonimmune balb c peritoneal macrophages on syngeneic lymphoma cells in vitro

Sacristan, M. D.; Wendt-Gallitelli, M. F., 1973: Tumorous cultures of crepis capillaris chromosomes and growth

Kuhn D.T.; Packert G., 1988: Tumorous head type mutants of the distal bithorax complex cause dominant gain and recessive loss of function in drosophila melanogaster

Johnson J.; Kilgore E.; Newmeyer W., 1985: Tumorous lesions of the hand

Kozlowski K.; Anderson R.J.; Hochberger O.; Sacher M., 1984: Tumorous osteomyelitis 2 cases

Daniels R.A.; Weisenfeld I., 1979: Tumorous phosphaturic osteo malacia report of a case associated with multiple hem angiomas of bone

Thompson W.D.; Shiach K.J.; Fraser R.A.; Mcintosh L.C.; Simpson J.G., 1987: Tumors acquire their vasculature by vessel incorporation not vessel ingrowth

Di Chiro G.; Doppman J.L.; Dwyer A.J.; Patronas N.J.; Knop R.H.; Bairamian D.; Vermess M.; Oldfield E.H., 1985: Tumors and arteriovenous malformations of the spinal cord assessment using magnetic resonance

Chuang, S.; Harwood-Nash, D., 1986: Tumors and cysts

Casazza, A. M.; Bellini, O.; Formelli, F.; Giuliani, F.; Lenaz, L.; Magrini, U., 1977: Tumors and dental and ocular abnormalities after treatment of infant rats with adriamycin

Abe, K., 1977: Tumors and hormones

Nicolov I.G.; Chernozemsky I.N., 1979: Tumors and hyperplastic lesions in syrian hamsters mesocricetus auratus following trans placental and neo natal treatment with cigarette smoke condensate

Stojchev M., 1986: Tumors and nontumorous lesions in adult wistar rats

Sumi Y.; Hamasaki T.; Miyakawa M., 1987: Tumors and other lesions induced in germ free rats exposed to aspergillus versicolor alone

Young R.A.; Webster W.S., 1985: Tumors and polycystic renal disease in two captive woodchucks marmota monax

Elkan, E.; Cooper, J. E., 1976: Tumors and pseudotumors in some reptiles

Rami Porta R.; Bravo Bravo J.L.; Aroca Gonzalez M.J.; Alix Treuba A.; Serrano Munoz F., 1985: Tumors and pseudotumors of the chest wall

Leese T.; Neoptolemos J.P.; West K.P.; Talbot I.C.; Carr Locke D.L., 1986: Tumors and pseudotumors of the region of the ampulla of vater an endoscopic clinical and pathological study

Brunisholz M.; Hodel K.; Brunner F.P.; Harder F.; Torhorst J.; Thiel G., 1984: Tumors and renal transplantation

Vallina Alvarez E.; Arribas Castrillo J.M.; Velasco Alvarez A.; Quiroga Prado L.; Carton Sanchez J.A.; Diaz Sanchez J., 1986: Tumors and sarcoidosis a 4 year follow up of 39 cases of sarcoidosis

Steinmeier R.; Huk W.; Fahlbusch R., 1988: Tumors and space occupying malformations of the calvarial bones

Hirvonen J.; Rinne A., 1981: Tumors and sudden death

Albert A.; Freedman M.; Perelson A.S., 1980: Tumors and the immune system the effects of a tumor growth modulator

Kraevskii N.A.; Pokrovskaya N.N., 1984: Tumors and tumor like lesions in children according to biopsy material for 5 years

Baron J.; Scharizer E., 1987: Tumors and tumor like lesions of the carpal bones

Beeson J.H.; Daynes R.A.; Weinert A.M.Jr; Gahring L.C., 1984: Tumors arising from injection of cultures murine placental cells into normal animals direct evidence for placental origin of tumors of 2 histologic types

Poroshin K.K.; Ingberman Ya Kh; Vavilov A.M.; Osadchaya V.V.; Normanskii V.E., 1982: Tumors arising in the epidermal cyst

Rettinger G.; Pfister R., 1982: Tumors around the jugular foramen diagnosis and clinical findings

Endresen L.; Schjerven L.; Rugstad H.E., 1984: Tumors from a cell strain with a high content of metallothionein show enhanced resistance against cis dichlorodiammineplatinum

Mookenthottathil, T., 1977: Tumors in 2 generations of mice in different environmental conditions

Strel'tsova, V. N.; Pavlenko-Mikhailov-Yu, N., 1978: Tumors in animals irradiated during embryogenesis

Ermoshchenkov, V. S.; Khudolei, V. V., 1976: Tumors in animals of the leningrad zoo

Loupal G.; Reifinger M., 1986: Tumors in birds in zoos in the wild and kept as companions

Geraci J.R.; Palmer N.C.; Saint Aubin D.J., 1987: Tumors in cetaceans analysis and new findings

Pokk L.R., 1979: Tumors in children

Smith R.H.Jr; Kovatch R.M.; Lijinsky W.; Thomas B.J.; Michejda C.J., 1987: Tumors in f344 rats by oral administration of 1 3 diethyltriazene

Tulinius, H.; Bjarnason, O.; Sigvaldason, H.; Bjarnadottir, G.; Olafsdottir, G., 1988: Tumors in iceland 10. malignant tumors of the female breast

Sigurjonsson, S. V.; Hallgrimsson, J.; Brekkan, A.; Haraldsson, S., 1979: Tumors in iceland 2. tumors and tumor like lesions of bone histological types and clinical course

Thorhallsson, P.; Tulinius, H., 1981: Tumors in iceland 3. malignant tumors of kidney a histological classification

Cooper, M. A.; Hallgrimsson, J., 1981: Tumors in iceland 4. tumors of the upper respiratory tract and ear a histological classification and some etiological and epidemiological considerations

Geirsson, G.; Johannesson, G.; Tulinius, H., 1982: Tumors in iceland 5. malignant tumors of the cervix uteri histological types clinical stages and the effect of mass screening

Perry, S. B.; Thorhallsson, P.; Hallgrimsson, J., 1982: Tumors in iceland 6. tumors of the urinary bladder ureter and urethra a histological classification and some epidemiological and environmental factors

Hallgrimsson, J.; Thorarinsson, H.; Tulinius, H., 1983: Tumors in iceland 7. malignant epithelial tumors of the lung a histological classification epidemiological considerations and relation to smoking

Agnarsson, B. A.; Olafsdottir, K.; Benediktsson, H., 1987: Tumors in iceland 8. hodgkin's disease and non hodgkin's malignant lymphomas a histological classification and epidemiological considerations

Bjarnason, O.; Tulinius, H., 1987: Tumors in iceland 9. malignant tumors of the ovary a histological classification epidemiological considerations and survival

Mcknight C.K.; Magnusson B., 1979: Tumors in iceland part 1 malignant tumors of skin a histological classification

Matz G.; Di Rosa F., 1979: Tumors in insects experimental studies on carausius morosus cheleutoptera

Zhang Y.; Et Al, 1986: Tumors in lateral cervical and parapharyngeal spaces

Svoboda D.J.; Azarnoff D.L., 1979: Tumors in male rats fed ethyl chlorophenoxy iso butyrate a hypo lipidemic drug

Pfeil C.; Loupal G., 1984: Tumors in the alimentary tract of the dog

Mueller W.; Bumb P., 1986: Tumors in the facial nerve canal

Watne K., 1986: Tumors in the pineal and suprasellar region a review of clinical manifestations and managements

Brand, K. G., 1976: Tumors induced by implanted instruments nature and possible control of etiologic factors

Chapdelaine J.M.; Plata F.; Lilly F., 1979: Tumors induced by murine sarcoma virus contain precursor cells capable of generating tumor specific cytolytic thymus derived lymphocytes

Weiland E.; Mussgay M., 1980: Tumors induced by progressor sarcoma virus moloney in mice growth in the presence of an immune response and isolation of autonomously growing cells

Toth, B.; Nagel, D., 1978: Tumors induced in mice by n methyl n formyl hydrazine of the false morel gyromitra esculenta

Van Hoof H.A.; Huttinga H.; Knaap A.; Maas Geesteranus H.P.; Mosch W.H.M.; De Raay Wieringa D.G.J., 1979: Tumors of begonia and some other ornamentals induced by corynebacterium fascians

Misdorp, W.; Van-Der-Heul, R. O., 1976: Tumors of bones and joints

Cortes T.; Raggio N.; Veppo A.A., 1981: Tumors of carotid body chemodectoma

Anglesio, E., 1976: Tumors of children in italy

Walker B.E., 1984: Tumors of female offspring of mice exposed pre natally to di ethyl stilbestrol

Dehner, L. P.; Askin, F. B., 1976: Tumors of fibrous tissue origin in childhood a clinico pathologic study of cutaneous and soft tissue neoplasms in 66 children

Leu H.J., 1982: Tumors of large vessels

Mateos Gomez J.H.; Loyo Varela M.; Porras Mendoza A., 1986: Tumors of pineal region report of 11 cases operated on by supracerebellar approach

Perez Castro J.A.; Ize Lamache L.; Granados Fraire N., 1981: Tumors of smooth muscle of the digestive tract

Isaka H.; Yoshii H.; Otsuji A.; Koike M.; Nagai Y.; Koura M.; Sugiyasu K.; Kanabayashi T., 1979: Tumors of sprague dawley rats induced by long term feeding of phenacetin

De-Benedittis, G.; Bernasconi, V.; Ettorre, G., 1977: Tumors of the 5th cranial nerve

Appleby, E. C., 1976: Tumors of the adrenal gland and paraganglia

Nakao N.L.; Siegel J.H.; Stenger R.J.; Gelb A.M., 1982: Tumors of the ampulla of vater early diagnosis by intra ampullary biopsy during endoscopic cannulation 2 cases and a review of the literature

Turusov, V. C., 1978: Tumors of the anal region induced in mice by 1 2 di methyl hydrazine

Kawaura A.; Kumagai H.; Shibata M.; Izumi K.; Otsuka H., 1981: Tumors of the anal region induced in mice painted with methylazoxy methanol acetate

Engel U.; Bay V.; Mier C., 1987: Tumors of the anterior mediastinum surgical treatment and prognosis

Sunba, M. S. N.; Rahi, A. H. S.; Morgan, G., 1980: Tumors of the anterior uvea 1. metastasizing malignant melanoma of the iris

Noor-Sunba, M. S.; Rahi, A. H. S.; Morgan, G., 1980: Tumors of the anterior uvea 2. intra nuclear cytoplasmic inclusions in malignant melanoma of the iris

Sunba, M. S. N.; Rahi, A. H. S.; Garner, A.; Alexander, R. A.; Morgan, G., 1980: Tumors of the anterior uvea 3. oxytalan fibers in the differential diagnosis of leio myoma and malignant melanoma of the iris

Uzeta Mejia S.; Garcia Diaz F.; Cervantes Chavez J.E.; Gomes Mejia A., 1979: Tumors of the appendix review of 15 years work at the general hospital of the la raza medical center of the mexican institute of social security

Ito, T. Y.; Martin, D. C., 1977: Tumors of the bladder in renal transplant patients report of a case of adeno carcinoma and review of known cases

Lusk M.D.; Kline D.G.; Garcia C.A., 1987: Tumors of the brachial plexus

Tyufanov A.V., 1987: Tumors of the brain choroid plexus caused by avian myeloblastosis virus

Abu Salih H.S.; Abdul Rahman A.M., 1988: Tumors of the brain in the sudan

Char G.; Cross J.N.; Persaud V., 1987: Tumors of the central nervous system analysis of 476 cases observed at the university hospital of the west indies

Guethert, H.; Warzok, R., 1979: Tumors of the central nervous system in biopsy and autopsy material 2. tumors and malformations of blood vessels

Schreiber, D.; Warzok, R.; Guethert, H.; Schneider, J., 1980: Tumors of the central nervous system in biopsy and autopsy material 4. glio blastomas

Schreiber, D.; Warzok, R.; Guethert, H., 1981: Tumors of the central nervous system in biopsy and autopsy material 5. oligodendro gliomas

Schneider, J.; Warzok, R.; Guethert, H.; Schreiber, D.; Poetzsch, H. D., 1981: Tumors of the central nervous system in biopsy and autopsy material 6. meningiomas

Schneider, J.; Warzok, R.; Schreiber, D.; Guethert, H., 1983: Tumors of the central nervous system in biopsy and autopsy material 7. neurinomas and neuro fibromatoses with central nervous system involvement

Warzok R.; Guethert H.; Schreiber D., 1979: Tumors of the central nervous system in biopsy and autopsy material astro cytomas

Warzok, R.; Guethert, H., 1978: Tumors of the central nervous system in biopsy and autopsy material part 1 frequency age and sex distribution

Kepes J.J.; Chen W.Y.K.; Pang L C.; Kepes M., 1984: Tumors of the central nervous system in taiwan

Englund E.; Brun A.; Larsson E M.; Gyorffy Wagner Z.; Persson B., 1986: Tumors of the central nervous system pmr relaxation times t1 and t2 and histopathologic correlates

Enzmann D.R.; Wheat R.; Marshall W.H.; Bird R.; Murphy Irwin K.; Karbon K.; Hanbery J.; Silverberg G.D.; Britt R.H.; Shuer L., 1985: Tumors of the central nervous system studied by computed tomography and ultrasound

Ho K L., 1982: Tumors of the cerebral aqueduct

Gross M.; Sorger K.; Schaub T., 1987: Tumors of the ceruminous glands

Parrella R.E.; Anzelmo V.; Bianco P.; Barbaro B.; Luna R., 1981: Tumors of the colon and rectum radiologic appearance and differential diagnosis

Vahala, Z.; Horova, M.; Plichtova, M., 1977: Tumors of the digestive tract with endocrine symptoms

Tamariz Martel Moreno A.; Madero Lopez L.; Munoz Villa A., 1987: Tumors of the endodermic sinus of testicular localization

Rajan A.; Sulochana S.; Sreekumaran T.; Nair M.K.; Reddi M.V., 1980: Tumors of the ethmoid mucosa in goats capra hircus

Lack E.E.; Cassady J.R.; Levey R.; Vawter G.F., 1983: Tumors of the exocrine pancreas in children and adolescents a clinical and pathologic study of 8 cases

Malik M.O.A.; El Sheikh E.H., 1979: Tumors of the eye and adnexa in the sudan

Mcentee, K.; Nielsen, S. W., 1976: Tumors of the female genital tract

Bogovskii S.P.; Nakonechnaya M.G.; Khomyakova L.G., 1987: Tumors of the gastrointestinal tract in rainbow trout

Marsman J.W.P., 1980: Tumors of the glomus jugulare complex chemodectomas demonstrated by cranial computed tomography

Bronshtein, M. E.; Yur'eva, N. P.; Golubeva, I. V., 1978: Tumors of the gonads in the testis dysgenesis syndrome

Headington, J. T., 1976: Tumors of the hair follicle a review

Deerberg F.; Rapp K.G.; Pittermann W.; Rehm S., 1980: Tumors of the han wistar rat

Smith C., 1986: Tumors of the heart

Fabian J.T.; Rose A.G., 1982: Tumors of the heart 89 cases

Ketkar, M.; Reznik, G.; Haas, H.; Hilfrich, J.; Mohr, U., 1977: Tumors of the heart and stomach induced in european hamsters by intra venous administration of n methyl n nitroso urea

Poole G.V.Jr; Breyer R.H.; Holliday R.H.; Hudspeth A.S.; Johnston F.R.; Cordell A.R.; Mills S.A., 1984: Tumors of the heart surgical considerations

Waldron C.A.; El Mofty S.K.; Gnepp D.R., 1988: Tumors of the intraoral minor salivary glands a demographic and histologic study of 426 cases

Nielsen, S. W.; Mackey, L. J.; Misdorp, W., 1976: Tumors of the kidney

Reifen E.; Feinmesser R.; Gay I., 1986: Tumors of the larynx in young adults

Liu D K., 1985: Tumors of the lateral ventricle of brain

Luo S., 1981: Tumors of the lateral ventricles in children

Smith R., 1979: Tumors of the liver

Ponomarkov, V.; Mackey, L. J., 1976: Tumors of the liver and biliary system

Santel L., 1980: Tumors of the liver in infancy and childhood

Head, K. W., 1976: Tumors of the lower alimentary tract

Marin-Trigo, J. M.; Candel-Calderon, M.; Sebastian-Arino, A.; Pierna-Saura, A.; Marco-Larraga, R., 1985: Tumors of the lung 1. epidemiology clinical and radiographic features

Marin-Trigo, J. M.; Sebastian-Arino, A.; Garces-Aranda, J.; Esteve-Mir, A.; Candel-Calderon, M., 1985: Tumors of the lung 2. diagnosis classification surgical management

Malhotra V.; Malik R.; Beohar P.C.; Gondal R.; Khanna S.K.; Naryanan P.S., 1986: Tumors of the lung a histomorphological study

Freidel M.; Beziat J.L.; Bertoin P.; Bouvier R.; Dumas P., 1981: Tumors of the mandibular condyle

Eveson J.W.; Cawson R.A., 1985: Tumors of the minor oropharyngeal salivary glands a demographic study of 336 cases

Rajan A.; Sulochana S.; Reddi M.V.; Sreekumaran T.; Ramachandran K.M.; Maryamma K.I.; Valsala K.V., 1981: Tumors of the mucosa of the ethmoid in pigs

Cardesa A.; Traserra J.; Bombi J.A.; Mohr U., 1984: Tumors of the nasal cavities induced in rats by 2 2 dioxopropyl n propylnitrosamine comparative aspects with man

Stunzi, H.; Hauser, B., 1976: Tumors of the nasal cavity

Khor, T. H.; Tan, B. C.; Chua, E. J.; Chia, K. B., 1975: Tumors of the naso pharynx singapore 1969 1971 the presenting picture

Valentini V.; Balducci M.; Ciarniello V.; De Santis M.; Lauriola L.; Stella C.; Taccari L.; Cellini N., 1987: Tumors of the nasopharynx review of 132 cases

Wilson J.; Holmsen R., 1983: Tumors of the nervous system epidemiology clinical presentation and methods of investigation in the norwegian county of akershus 1974 1978

Eggers, H.; Jakobiec, F. A.; Jones, I. S., 1976: Tumors of the optic nerve

Westman-Naeser, S.; Naeser, P., 1978: Tumors of the orbit diagnosed by fine needle biopsy

Beltran J.; Noto A.M.; Chakeres D.W.; Christoforidis A.J., 1987: Tumors of the osseous spine staging with mr imaging versus ct

Carter R.L.; Ird E.A., 1976: Tumors of the ovary

Magnin G.; Chuzel J.L.; Raudrant D.; Bremond A.; Rochet Y., 1979: Tumors of the ovary in young women the way they arise and the limits of conservative treatment

Kircher, C. H.; Nielsen, S. W., 1976: Tumors of the pancreas

Som P.M.; Braun I.F.; Shapiro M.D.; Reeds D.L.; Curtin H.D.; Zimmerman R.A., 1987: Tumors of the parapharyngeal space and upper neck mr imaging characteristics

Estrada Sarmiento M.; Pinilla Gonzalez R., 1986: Tumors of the parotid gland

Lam K.H.; Wei W.I.; Lau W.F., 1986: Tumors of the parotid the value of clinical assessment

Charachon R.; Cruzet G.; Vasdev A.; Gratacap B., 1988: Tumors of the petrous apex a clinical series

Bennington, J. L.; Holmes, E. J.; Combs, J. W., 1976: Tumors of the pilo sebaceous unit induced in the rat by the intra venous administration of 7 12 di methyl benz a anthracene

Wara W.M.; Jenkin R.D.T.; Evans A.; Ertel I.; Hittle R.; Ortega J.; Wilson C.B.; Hammond D., 1979: Tumors of the pineal and suprasellar region childrens cancer study group treatment results 1960 1975 a report from childrens cancer study group

Casenave P.; Eresue J.; Guibert Tranier F.; Piton J.; Caille J M., 1984: Tumors of the pineal region diagnostic problems

Tucker, W. G.; Leong, A. S. Y.; Mcculloch, G. A. J., 1977: Tumors of the pineal region neuro radiological aspects

Trabulo A.; Sereno M.; Baptista A.; Maymone D.; Goncalves C.; Reis N.; Bello R.; Da Costa R., 1987: Tumors of the posterior cranial fossa review of cases at the neurosurgical department from 1980 1984

Hiraga, K.; Fujii, T., 1977: Tumors of the preputial gland in rats

Hall, W. C.; Nielsen, S. W.; Mcentee, K., 1976: Tumors of the prostate and penis

Nkandi, L. L.; Ntumba, T.; Kagarari, M., 1978: Tumors of the prostate in zaire review of 309 cases

Warzok R.; Schreiber D.; Blaufuss E., 1979: Tumors of the rat kidney induced by nitroso urea compounds

Steffens J.; Nagel R., 1988: Tumors of the renal pelvis and ureter observations in 170 patients

Wheelis R.F.; Yarington T.Jr, 1984: Tumors of the salivary glands comparison of frozen section diagnosis with final pathologic diagnosis

Erlemann R.; Davies A.M.; Edel G.; Wuisman P.; Peters P.E.; Grundmann E., 1988: Tumors of the scapula assessment of dignity prior to biopsy

Papis, E. I., 1977: Tumors of the small intestinal mesentery based on data of the dnestrovsk city hospital

Kopriva, V.; Bilkovic, R.; Licko, T., 1977: Tumors of the small intestine

Aguilar Luque J.; De Castro Lorenzo J.; Madrazo Leal C., 1987: Tumors of the small intestine analysis of 19 cases

Feil W.; Schulz F., 1985: Tumors of the small intestine diagnosis treatment and prognosis

Dong H J.; Huang S Z.; Huang S W., 1986: Tumors of the small intestine report of 131 cases and review of 1024 cases in the literature

Gonzalez Gonzalez J.J.; Alvarez Perez J.A., 1986: Tumors of the small intestine results follow up of one to nine years

Cardevilla Azoy C.; Guarnaluce Brooks R.; Perez Fernandez A.; Vazquez Bandera A., 1985: Tumors of the small intestine review of thirteen cases operated at 10 de octubre clinicosurgical teaching hospital cuba

Olmsted W.W.; Ros P.R.; Hjermstad B.M.; Mccarthy M.J.; Dachman A.H., 1987: Tumors of the small intestine with little or no malignant predisposition a review of the literature and report of 56 cases

Carmona Saez J.A.; Aizcorbe Garralda M.; Guarch R.; Alberdi Ibanez I.; Diaz De Liano A., 1987: Tumors of the smooth muscle of the small intestine 10 cases

Verlohren G., 1982: Tumors of the spine as differential diagnosis for tuberculous spondylitis

Mostofi F.K.; Bresler V.M., 1980: Tumors of the testis

Baldetorp, L. A.; Henrikson, H.; Ingemansson, S.; Ling, L., 1976: Tumors of the testis a report of 128 cases

Wobbes T.; Hoekstra H.J.; Sleyfer D.T.; Koops H.S., 1981: Tumors of the testis in 2 brothers a case

Junaid T.A., 1982: Tumors of the testis in ibadan nigeria

Alvarez C.A.; Gonzalez G.J.; Trodler C.R.; Rivero M.A.; Ranieri H.R., 1981: Tumors of the testis role of high technology hospitals in their diagnosis and management

Beks J.W.F.; Bouma G.J.; Journee H.L., 1987: Tumors of the thalamic region a retrospective study of 27 cases

Coman C.; Stan A.; Micu V.; Scurei A.; Dimitriu M.; Zara D.; Coman B.C., 1984: Tumors of the thoracic wall 158 operated cases

Diniz J.M.F.; Nogueira R.H.G.; Souza J.C.D.; Da Silva J.M.L.; Do Nascimento E.F.; Chquiloff M.A.D., 1981: Tumors of the thyroid gland in the dog

Head, K. W., 1976: Tumors of the upper alimentary tract

Maekawa, A.; Kamiya, S.; Odashima, S., 1976: Tumors of the upper digestive tract of aci n rats given n propyl n nitroso urethane in the drinking water

Cukier J.; Abourachid H.; Pascal B.; Sueur J P.; Merimsky E., 1981: Tumors of the upper excretory tract a series of 130 cases

Mazeman, E., 1976: Tumors of the upper urinary tract calyces renal pelvis and ureter

Amico F.; Vacirca F., 1980: Tumors of the urachus a case

Krzeski, T.; Witeska, A.; Zachwiej, J., 1978: Tumors of the urinary bladder accidentally diagnosed during prostatectomy

Ringenberg Q.S.; Doll D.C.; Yarbro J.W.; Perry M.C., 1986: Tumors of unknown origin in the bone marrow

Johansson, S.; Wahlqvist, L., 1977: Tumors of urinary bladder and ureter associated with abuse of phenacetin containing analgesics

Lopez, J. F.; Pilichowski, P.; Caravel, J. P.; Rambeaud, J. J.; Hosatte, F.; Faure, G., 1987: Tumors of zuckerkandl's organ

Shigematsu, S.; Tanimura, A., 1976: Tumors originating from the testicular tunics a classification of these tumors

Cronin M.J.; Reches A.; Macleod R.M.; Login I.S., 1983: Tumors producing chronic hyper prolactinemia do not alter tritium labeled spiperone binding and dopamine turnover in the corpus striatum of the female rat

Oliff A.; Defeo Jones D.; Boyer M.; Martinez D.; Kiefer D.; Vuocolo G.; Wolfe A.; Socher S.H., 1987: Tumors secreting human tnf cachectin induce cachexia in mice

Odeku, E. L.; Adeloye, A.; Williams, A. O.; Osuntokun, B. O., 1976: Tumors within the spinal column

Bengtson S.; Fedorov A.B.; Missarzhevsky V.V.; Rozanov A.Yu; Zhegallo E.A.; Zhuralev A.Yu, 1987: Tumulduria incomperta and the case of tommotian trilobites

Swanson, R.; Trus, B. L.; Mandel, N.; Mandel, G.; Kallai, O. B.; Dickerson, R. E., 1977: Tuna cytochrome c at 2.0 angstrom resolution part 1 ferri cytochrome structure analysis

Takano, T.; Trus, B. L.; Mandel, N.; Mandel, G.; Kallai, O. B.; Swanson, R.; Dickerson, R. E., 1977: Tuna cytochrome c at 2.0 angstrom resolution part 2 ferro cytochrome structure analysis

Mandel, N.; Mandel, G.; Trus, B. L.; Rosenberg, J.; Carlson, G.; Dickerson, R. E., 1977: Tuna cytochrome c at 2.0 angstrom resolution part 3 coordinate optimization and comparison of structures

Hadeishi T.; Koizumi H.; Mclaughlin R.D.; Millaud J.E., 1982: Tunable atomic line molecular spectrometer

Morelli J.G.; Tan O.T.; Garden J.; Margolis R.; Seki Y.; Boll J.; Carney J.M.; Anderson R.R.; Furumoto H.; Parrish J.A., 1986: Tunable dye laser 577 nanometers treatment of port wine stains

Lewis, A.; Spoonhower, J.; Bogomolni, R. A.; Lozier, R. H.; Stoeckenius, W., 1974: Tunable laser resonance raman spectroscopy of bacterio rhod opsin

Polla L.L.; Tan O.T.; Garden J.M.; Parrish J.A., 1987: Tunable pulsed dye laser for the treatment of benign cutaneous vascular ectasia

Bingham A.Jr; Wilkie D.W.; Mosher H.S., 1979: Tunaxanthin occurrence and absolute stereochemistry

Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file: